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Association of Hypertension Perceptions and Antihypertensive Medication Adherence 
Among Black Hypertensive Adults in Primary Care Settings. 
By Stella Eke, DNP, RN, FNP-C 
May, 2018 
Black adults with hypertension are more likely to have uncontrolled hypertension 
and suffer more complications than Whites, partially due to decreased medication 
adherence among Black patients.  Several studies have found that Black adults with 
hypertension have numerous misconceptions about it and its management; however, few 
studies have examined hypertension perceptions in relation to antihypertensive 
medication adherence.  
  Using the common-sense model of perception and self-regulation of illness as the 
theoretical framework, this cross-sectional study aimed to investigate the relationship 
between hypertension perceptions and medication adherence among Black hypertensive 
adults 35 to 65 years old in primary care settings.  It also examined the factor structure of 
hypertension causal attributions and explores gender differences in hypertension 
perceptions and medication adherence. 
 A nonprobability sample of 118 Black hypertensive adults 35 to 65 years old was 
selected as they presented in four primary care clinics.  Instruments included the revised 






 The sample was middle aged (M = 53.9; SD = 7.9 years), 52.5% male, and mostly 
educated, with 51% having a four-year college degree or higher.  Using principal 
components factor analysis, two factors emerged, which explained 40.8% variance in 
causal attributions: items related to unhealthy lifestyle choices and factors outside the 
individual’s control, and items related to life stressors and known predisposing factors for 
hypertension.  Using multiple regression while controlling for covariates, three IPQ-R 
subscales (Cyclical Timeline, Consequences, and Emotional Representation) explained 
23.9% variance in medication adherence, F (6, 111) = 5.82, p < .001; however, only 
Consequences had a significant relationship with medication adherence (p = .022).  Using 
ANCOVA, only one of the subscales had a significant gender difference; males had 
higher (p = .034) adjusted mean scores (M = 16.2, SE = .64.) than females (M = 14.2, SE 
= .67) for the perception that hypertension is caused by unhealthy lifestyle choices and 
factors outside an individual’s control.                                                                                                                                              
  Although these findings could be applied to similar patient populations in primary 
care, variation in antihypertensive medication adherence is largely unexplained and needs 
further research.  A longitudinal study with a larger sample size could further examine 
and clarify hypertension beliefs among Black hypertensive adults. 
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Summary of Study  
 
The focus of this observational cross-sectional study was to examine the 
association between perceptions about hypertension and medication adherence among 
Black hypertensive adults 35 to 65 years of age in primary care settings.  An additional 
focus was to investigate the causal attributions of hypertension as well as explore any 
gender differences in hypertension perceptions and medication adherence.   
The study was conducted as outlined in the proposal, and the aims, methods, 
analyses, and results reflect the content of the study proposal.  There was no deviation 
from the proposal.  The proposal outlines the specific aims, significance of the problem, 
proposed methods, and analyses, while the manuscript outlines the execution of the 


















Cardiovascular disease (CVD) remains the leading cause of death in the United 
States (American Heart Association [AHA], 2015). Furthermore, the AHA (2017a) 
reported that among Black adults 20 years and older, 46% of males and 47.7% of females 
have CVD. CVD caused the death of 49,210 Black males and 48,573 Black females in 
2014 (AHA, 2017a). Hypertension (HTN) is the leading cause of CVD (Valderrama, 
Gillespie, & Mercado, 2013). Among non-Hispanic Blacks aged 20 years and older, 45% 
of males and 46.3% of females have hypertension (AHA, 2017b).  Uncontrolled 
hypertension is considered an important risk factor for coronary heart disease, stroke, 
congestive heart failure, end-stage renal disease, and peripheral vascular disease (AHA, 
2017a; Sulainman et al., 2009). Compared with Whites, Blacks develop hypertension 
earlier, have higher average blood pressure and poorer blood pressure control, causing 
Blacks with hypertension to have 1.3 times greater rate of nonfatal stroke, 1.8 times 
greater rate of fatal stroke, 1.5 times greater rate of heart disease death, 4.2 times greater 
rate of end-stage kidney disease, and 50% higher frequency of heart failure (AHA, 2015; 
Go et al., 2014). 
 Although 80.8% of Blacks are aware of their hypertension, and 71.9% are under 
treatment, only 43% have their hypertension under control (Valderrama & Gillespie, 2013). 
Black adults are more likely to be non-adherent to antihypertensive medications or have 
uncontrolled hypertension than other races (Dickinson & Plauschinat, 2008; Redmond, Baer, 





adults on Medicaid were 50% less adherent to medications than Whites; another longitudinal 
cohort study among hypertensive Medicaid recipients found that African American patients 
were less adherent to medications than Whites (55% vs. 61%, p < .05) (Dickson & 
Plauschinat, 2008). 
Having a better understanding of the critical factors impeding medication 
adherence and hypertension among Black hypertensive adults will inform the design of 
meaningful interventions to curtail the alarming burden of uncontrolled hypertension 
among Blacks.  Factors affecting medication adherence among Black hypertensive adults 
seem to be multifaceted.  A systematic review by Lewis (2012) explored several factors 
theorized by researchers to impact medication adherence among Blacks, including 
healthcare system, nature of hypertension as an often-non-symptomatic disease, treatment 
complexity, presence of other comorbidities, and patient-related issues. Furthermore, 
numerous qualitative studies have found that Black adults have misconceptions about 
hypertension (Ogedegbe et al., 2004; Lukoschek, 2003; Wilson et al., 2002), but only a 
few studies have explored the relationship between these misconceptions and medication 
adherence (Heckler et al., 2008; Heurtin-Roberts & Resisin, 1990).  
 The main objective of the current study is to explore whether there is an 
association between hypertension perceptions and medication adherence among Black 
hypertensive adults after controlling for certain factors that affect medication adherence 
and illness perceptions and, furthermore, to investigate participants’ perceptions about 
causes of their hypertension.  Additionally, the present study intends to explore whether 
there are gender differences in hypertension perceptions.  Most of the existing knowledge 





female samples.  The long-term goal and research trajectory will focus on designing a 
theory-based randomized clinical trial using intervention strategies that promote better 
understanding of hypertension, medication adherence, and blood pressure control among 
Black hypertensive adults. 
The central hypothesis in the present study is that perceptions about hypertension 
as it relates to disease timeline, controllability, consequences, emotional representation, 
illness coherence, and cause will be associated with medication adherence among Black 
hypertensive adults aged 35 to 65 years old being treated for hypertension in primary care 
settings.  
Specific Aims and Hypotheses 
Aim #1: To investigate participants’ perceptions about causes of hypertension. 
Hypothesis #1: Compared to other factors, perception of psychological factors as a cause 
of hypertension will explain the highest variance in views about the cause of 
hypertension.  
Aim #2: To examine the relationship between medication adherence and hypertension 
perceptions as related to views about hypertension timeline, controllability, 
consequences, emotional representation, illness coherence, and cause among Black 
hypertensive adults 35 to 65 years old, while controlling for depression, educational 
level, duration of diagnosis, hypertension-related symptom, and severity of hypertension. 
Hypothesis #2: There will be a statistically significant relationship between medication 
adherence and hypertension perceptions. 
Aim #3: To explore to what extent hypertension perceptions and medication adherence 





Background and Significance  
 When compared to Whites, Blacks develop hypertension earlier, have higher 
average blood pressure, and have poorer blood pressure control—all of which lead to 
Blacks with hypertension having a 1.3 times greater rate of nonfatal stroke, 1.8 times 
greater rate of fatal stroke, 1.5 times greater rate of heart disease death, 4.2 times greater 
rate of end-stage kidney disease, and a 50% higher frequency of heart failure (Go et al., 
2014).  In addition, 30-year mortality risk among White hypertensive men was 23.8% 
compared to 45.2% from Black hypertensive men, and 18.3% for White women 
compared to 39.5% for Black women (Lackland, 2014).  Non-Hispanic Blacks had 90% 
higher odds of poorly controlled hypertension compared to non-Hispanic Whites, even 
after controlling for socioeconomic status, gender, age, and other clinical factors 
(Redmond, Baer & Hicks, 2011).  Even though there has been advancement in treatment 
options for hypertension and other cardiovascular disease risk factors over the years, 
uncontrolled hypertension remains a public health burden in the United States 
(Mozaffana et al., 2015; Chobanian, 2015).  Furthermore, Chobanian (2015) asserts that 
evidence has shown that these advanced antihypertensive options are effective in 
controlling hypertension in anyone, irrespective of race.  Nevertheless, only 43% of 
Black hypertensive adults have their blood pressure under control (Valderrama & 
Gillespie, 2013).   
Studies have noted that even Black hypertensive adults on government-sponsored 
insurance, such as Medicaid, are less adherent to antihypertensive medication compared 
to their White counterparts.  Shaya et al. (2009) examined predictors of antihypertensive 





50% less adherent to medication compared to their White counterparts; additionally, 
another study by Dickson and Plauschinat (2008) reported a significant difference in 
medication adherence among Black hypertensive adults compared to Whites (55% vs. 
61%; p < .05). 
The AHA projects cost of medical care for hypertension will increase from $69.9 
billion in 2010 to $200.3 billion in 2030 (Heidenreich, 2011), while the Center for 
Disease Control and Prevention ([CDC], 2016) reports that hypertension costs $48.6 
billion yearly.  According to the Agency for Healthcare Research and Quality ([AHRQ], 
2013), in 2010 direct medical expenditure for hypertension totaled 42.9 billion, with a 
higher percentage of non-Hispanic Blacks (30.4%) being treated for hypertension than 
non-Hispanic Whites (26.7%); furthermore, annual expenditure for those treated for 
hypertension averaged $733 per adult, while mean expenditure per person with 
hypertension was $887 for Blacks, compared to $679 per person for non-Hispanic 
Whites.   
There is a need for future research to focus on populations with the highest 
prevalence of uncontrolled hypertension and its complications (Levine et al., 2011).  The 
current study chose to focus on Black hypertensive adults, aged 35 to 65 years, because 
this is about the age where the onset and prevalence of hypertension is generally high. 
Although individuals start developing hypertension around middle age, Blacks develop 
hypertension at an even younger age (CDC, 2016; AHA, 2016).  Targeting hypertensive 
patients within this age group (35 to 65 years) for interventions to improve understanding 





future negative outcomes that could emanate from uncontrolled hypertension among 
Black hypertensive adults.  
The current study is focusing on Black hypertensive adults with a history of 
primary hypertension for at least 12 months and who have ever been prescribed 
antihypertensive medication or are currently taking at least one antihypertensive 
medication.  Restricting recruitment to patients within these parameters eliminates the 
chance for including newly diagnosed hypertensives that have yet to comprehend or 
adjust to their diagnoses or patients with borderline hypertension who may not have been 
prescribed medication but are on lifestyle modification instead.   
The World Health Organization ([WHO], 2003) defines medication adherence as 
the extent to which a patient’s medication-taking behavior matches with agreed 
recommendations from a healthcare provider.  Medication adherence is further defined as 
the degree to which a patient follows recommended or prescribed medications by their 
healthcare providers as it relates to timing, dosing, and frequency (Cramer et al., 2008).  
According to the WHO (2003), the patient should be considered an active collaborator in 
their treatment rather than a passive recipient of advice from healthcare providers.  
Medication non-adherence remains a problem among Black hypertensive adults.  
The reason for medication non-adherence among Blacks seems complex and 
multifaceted. Individual studies have outlined factors such as poor socioeconomic status, 
distrust for physicians, racial discrimination, comorbidities, disease-related problems 
(such as absence or presence of symptoms), complexity of medication regimen, patient-
provider communication, depression, and a fatalistic view of hypertension (Greer, 2010; 





study with a majority-Black-hypertensive-adult sample noted that patient-provider 
interaction that does not involve the patient or involve patients’ sociodemographic needs 
often leads to poor medication adherence (Schoenthaler, Knafl, Fiscella, & Ogedegbe, 
2017).   As noted earlier, the most recent systematic review on factors affecting 
medication adherence among Black hypertensive adults reported that medication 
adherence or non-adherence was consistently associated with self-efficacy; depression; 
patient-provider communication and system-related factors; disease-related factors, such 
as presence or absence of symptoms; and severity of hypertension (Lewis, 2012).  
Although several assertions have been made to explain the poor therapy 
adherence among Black hypertensive patients, the solution to this problem remains 
difficult and elusive (Kressin, Orner, Manze, Glickman, & Berlowitz, 2010).  Most of the 
existing interventions to address some of these problems have only yielded inconclusive 
or non-promising results; thus, the need to explore other potential contributing factors, 
such as illness perception. 
Middleton (2009) suggested that the lower rates of adherence to prescribed 
therapy for hypertension, including exercise, diet, and medication, among Black 
hypertensive adults may be related to the inaccurate illness perceptions held about 
hypertension that are not consistent with a biomedical disease model of hypertension.  
Ross et al. (2004) discussed the effect of illness beliefs on predicting medication 
adherence, and further reported that patients who do not perceive hypertension to be 
serious may self-regulate their antihypertensive medications accordingly.  The authors 
further asserted that targeting patients’ health beliefs may be important in designing 





a sample of 19 African-American, 20 White, and nine Hispanic Veterans Administration 
patients reported that among other factors, patients’ perceptions of the cause, course of 
hypertension, and experiences of hypertension symptoms were linked with their reports 
of their self-management behaviors (Bokhour et al., 2012). Furthermore, in a quantitative 
study by Rajpura and Nayak (2014), with a sample that was made up of 76.9% Whites 
and 18.8% Blacks, aged 55 years and older, more favorable perceptions of illness were 
associated with higher medication adherence scores (p = .001).  Several qualitative 
studies have reported worrisome levels of misconceptions about hypertension among 
Black hypertensive adults (Boutin-Foster, Ogedegbe, Ravenell, Robins, & Charlson, 
2007; Ogedegbe, Mancuso, & Allegrante, 2004; Schlomann, & Schmitke, 2007; Wilson 
et al., 2002).   
Illness perception is conceptually defined as an individual’s beliefs or cognitive 
understanding about an illness (Leventhal et al., 2003).  A deeper understanding of illness 
perception has been shown to be useful in assessing patients’ illness outcomes (Figueria 
& Alves, 2006; Hagger & Orbell, 2003).  When faced by a health threat, an individual 
cognitively evaluates and tries to make sense of the health threat, after which the 
individual is likely to develop a coping mechanism that is guided by the level of risk 
perceived about the illness.  These beliefs can be shaped by medical knowledge through 
interaction with healthcare providers, personal experiences, and/or experiences of others, 
such as family or friends (Petrie & Weinman, 2006).  An individual that holds a 
misguided perception or understanding about the cause, complications, timeline, 
controllability/cure, and chronicity of hypertension is likely to be non-adherent to 





The self-regulation of health and illness model, also called the common-sense 
model (Leventhal, Brissette, & Leventhal, 2003), serves as the theoretical guiding 
framework for this study.  This model emphasizes the role of illness perception in 
guiding coping behaviors toward an illness, which subsequently affect illness outcomes.  
The model proposes that in response to a health threat, individuals may develop both 
parallel cognitive and emotional representations, which in turn give rise to problem-based 
and emotional-focused coping behaviors (Leventhal et al., 2001).  The authors assert that 
response to illness involves three processes, namely representation, coping, and appraisal.  
The model posits that the mental impressions patients attach to the identity 
(symptoms), duration of illness, illness outcome/consequences, causal factors, and 
curability guide their coping mechanism toward the illness.  When faced with a health 
threat, the individual tries to develop a cognitively reasoned understanding of the health 
threat, eventually develops a coping mechanism based on personal mental representation 
of the illness, and, finally, with time, appraises such coping mechanisms.  In this study, 
the coping behavior of interest is medication adherence versus non-adherence. 
 If a patient cognitively perceives an illness such as hypertension to be non-life 
threatening, adherence to medication may be low.  Furthermore, when an individual 
perceives hypertension to be chronic, they may have a different behavioral plan on how 
to manage or cope with the illness than when it is perceived to be episodic, acute, or 
temporary.  
The self-regulation of health and illness model identifies five constructs of illness 
representation as follows (Leventhal et al., 2003):   









Identity represents the label a patient assigns to personal symptoms or perception of 
symptoms associated with the illness.  Timeline represents the patient’s perception of the 
duration of illness in terms of whether the illness is acute/temporary, chronic, or cyclical 
in nature.  Consequence signifies the level of threat or complications perceived to be 
associated with the illness.  Cause represents perceived etiology of the illness as it relates 
to external or internal factors or stressors.  Finally, Control or Cure represents what the 
individual thinks about the controllability or curability of the illness by medication, 
and/or whether he/she can do what is needed to control the disease.  
This model fits very well into the present study in that patients with high blood 
pressure often misconceive the disease as a non-life-threatening illness, especially due to 
its mostly asymptomatic nature.  A misguided view of hypertension may lead to non-
adherence behavior with prescribed medication.  This is particularly important among 
Black adults as studies have reported that most Blacks attribute hypertension to stress and 
often engage in stress-management activities to control hypertension at the expense of 
medications (Heckler et al., 2008; Heurtin-Roberts, 1990; Rose, Kim, Dennison, & Hill, 
2000; Wilson et al., 2002).  
This problematic misconception of hypertension due to its mostly asymptomatic 
nature has led some patients to question their diagnoses of hypertension and the need for 





hypertension often adjust their medication based on symptoms, which may be very 
deceiving since lack of symptoms does not necessarily indicate the absence of elevated 
blood pressure or hypertension (Schlomann, & Schmitke, 2007)—thus the reason 
hypertension is called a silent killer. 
Literature review on perceptions about hypertension among Black hypertensive 
adults.  A qualitative study with a sample of 93 African-American hypertensive adults 
reported that a good proportion of patients had nonbiomedical misconceived expectations 
of their treatment, where 38% expected a cure for their hypertension, 38% did not expect 
to take their medications for life, and 23% took medications only with symptoms 
(Ogedegbe et al.2004).  Boutin-Foster et al. (2007) conducted a qualitative study among a 
sample of 60 African Americans with uncontrolled hypertension using structured 
interviews.  This study found that Black adults with family members who had 
experienced complications from hypertension are more likely to perceive hypertension as 
a serious disease, and, furthermore, those who experience symptoms from hypertension 
and have family members with a history of hypertension were more likely to adhere to 
recommended therapy to control their high blood pressure. 
Some Blacks do not perceive hypertension as a disease arising from a 
pathological process, but rather perceive it to be self-regulating and, thus, requiring no 
medication or medical treatment.  In addition, some view hypertension as an expected 
adjustment to stressful life events (Lukoschek, 2003; Ogedegbe et al., 2004).  A focus 
group interview of 112 to 128 adherent and non-adherent low SES Black hypertensive 
adults 30 to 65 years old revealed that some perceived hypertension to be a different 





stress and emotional state, while high blood pressure is caused by “thick blood and 
arteries” and is not curable (Lukoschek, 2003).  Furthermore, hypertension was also 
perceived as a disease that always has symptoms.  Wilson et al. (2002) investigated the 
lay beliefs about high blood pressure among 167 Blacks, 18 to 74 years old.  This study 
found that some of the participants attributed high blood pressure to eating pork and other 
foods that were perceived as making “blood travel fast to the head,” while some 
described high blood pressure as “elevated blood vessels.”  In addition, the authors noted 
that some of the participants had the perception that high blood pressure can be cured 
with vitamins, garlic, and herbs. In a qualitative study using a sample of 42 Black 
hypertensive adults 30 to 65 years (66.7% women), Lukoschek (2003) reported that 
participants believed that hypertension is a separate disease from high blood pressure, 
where high blood pressure is a physiological disease while hypertension results from 
emotional or psychological state.  Another qualitative study using 47 Black women noted 
that though hypertension is seen as a serious disease, the cause was attributed to 
psychological stress (Webb & Gonzalez, 2006). 
The literature search revealed that only a few studies have examined the 
relationship between perceptions of hypertension and medication adherence among Black 
hypertensive adults.  An older study by Heurtin-Roberts and Reisin (1992) assessed the 
relationship between lay beliefs about hypertension and medication adherence among 60 
Black hypertensive women attending a public-hospital-based clinic in New Orleans using 
field notes, medication diaries, and pill count and found a significant association between 
illness perception and treatment adherence behaviors (p = .01 and .001).  Participants 





likely to be non-adherent with their medications compared to those who had biomedical 
views of hypertension (relative risk = 2.3; 95% CI [1.2-4.4]).  Heckler et al. (2008) 
carried out the most recent study on the impact of perception or common-sense illness 
beliefs on therapy adherence among 102 Black adult hypertensive patients.  This study 
found that perception of stress as the cause of hypertension correlated (r = .34, df = 100, 
p < .01) with engaging in stress-reducing behaviors to manage high blood pressure at the 
expense of medication and lifestyle modifications, while beliefs in the biomedical model 
of hypertension weakly correlated with medication adherence and lifestyle modifications 
to control high blood pressure (r = - .21, df = 100, p < .05). 
Some intervention studies, with sample sizes ranging from 55 to 1,059, did not 
directly target hypertension perceptions but instead aimed at improving understanding of 
hypertension, medication adherence, and blood pressure control or reduction among 
Black hypertensive adults; these studies have reported mostly non-significant differences 
in blood pressure control or reduction between the intervention and control groups from 
baseline to follow-up (Greer et al., 2015; Ogedegbe et al., 2008; Johnson et al., 2011; 
Roberts et al., 2012; Ogedegbe et al., 2014; Webb, 1980).   
There is an obvious gap in knowledge: Though qualitative studies have elicited 
various levels of misconceptions about hypertension among Black adults, there have not 
been many quantitative studies exploring the relationship between these misconceptions 
about hypertension and medication adherence.  Most of what is known about 
hypertension perception among Black adults has been based on qualitative studies with 





explored the association between hypertension perception and medication adherence 
among Black hypertensive adults was in 2008. 
To address this gap in knowledge, the central aim of the present study is to 
examine the association between hypertension perceptions and medication adherence 
among Black hypertensive adults 35 to 65 years old being treated for hypertension in 
primary care settings and to examine whether there will be any gender differences in 
hypertension perceptions and medication adherence.  
Innovation. The present study of the association between hypertension 
perceptions and medication adherence is the first to focus specifically on Black 
hypertensive adults 35 to 65 years old in primary care.  Recruiting participants from 
multiple primary care clinics will produce a sample that is not only heterogeneous, but 
also representative of the population of interest.  The findings of the present study will 
help expand the knowledge-base about the association between hypertension perceptions 
and medication adherence among this population.  Most of what is currently known about 
hypertension perceptions among Black hypertensive adults have been based solely on 
qualitative studies.  This study will be one of the few studies that examine the association 
between hypertension perceptions and medication adherence, where hypertension 
perceptions will be measured quantitatively, allowing for analysis of the relationship 
between these two variables.  The validity of the findings of this study will be enhanced 
by controlling for most of the important confounding factors known to impact medication 
adherence and illness perceptions.  The present study will also highlight whether there are 
gender differences in hypertension perceptions and medication adherence.  Most of what 





among Black adults has been based on studies with samples that were majority female, 
however, the present study will attempt to recruit a good representation of both genders.  
Approach 
Research design and setting.  This is an observational cross-sectional research 
design study.  A non-probability sampling method will be used in recruiting participants 
into the study.  Potential participants will be recruited concurrently from four primary 
care clinics in the Houston TX metropolitan area.  One clinic is an employee-based 
primary care clinic, while the other three are internal medicine or family primary care 
clinics that serve large populations of Black hypertensive adult patients.  Recruitment 
from the clinics will occur in person as the patients present for their regularly scheduled 
appointments with their healthcare providers. Participants’ voluntary participation will be 
sought by the principal investigator (PI) in the waiting area or lobby of the clinics.  
Additionally, recruitment flyer will be placed in the lobby and examination rooms of the 
clinics so that potential participants whose doctors’ visits occur when the PI is not present 
in the clinic will have the opportunity to contact the PI if interested in study participation. 
The rationale for recruiting from several clinics is two-fold: to recruit a sample 
that will be representative of the intended patient population and to counteract the chance 
for low response rate that could occur if recruitment is limited to only one or two sites.  
Studies have suggested that Blacks tend to be hesitant with participating in research 
studies due to mistrust for the healthcare system (Scharff et al., 2010; Kennedy, Mathis, 
& Wood, 2007).  In addition to recruiting from multiple sites, other strategies to improve 
participation include offering compensation; ensuring convenience by completing the 





to-face interaction since in-person reassurance increases comfort with the research 
process (Satia, Galanko, & Rimer, 2005); and offering tangible incentives (Qualls, 2002). 
Each participant will receive a $15 gift card to Wal-Mart or Starbucks in appreciation for 
their time and effort, which should in turn improve response rate.  Gift card incentives 
were found to be one of the predictors of increased survey response rate among African 
Americans (Liu, & Geidenberger, 2011). Lukoschek (2003) and Heckler (2008) 
compensated their respective sample of hypertensive Black adults in an amount ranging 
from $10 to $15.   
Approval to conduct the study will be obtained from the University of Texas 
Health Science Center-Houston Institutional Review Board (IRB). Written permission to 
recruit patients and conduct chart review will be obtained from each of the clinics’ 
management.  Consent will be obtained from each participant for participation and chart 
review.  Recruitment is anticipated to last up to three months. Validated instruments will 
be used to collect data on the dependent variable (medication adherence) and independent 
variables (illness perceptions), while a short form will be designed to collect 
demographic data and information about potential confounders.  The purpose of the chart 
review is to verify information about demographic characteristics, confounders, and 
eligibility criteria.  
Sample selection criteria. The sample selection criteria are as follows: 
Inclusion Criteria. (a) Self-identified Black adults; (b) males and females, aged 
35 to 65 years;  (c) diagnosis of primary/essential hypertension (PI will confirm during 
chart review); (d) duration of hypertension diagnosis for at least 12 months (PI will 





hypertensive medication (PI will confirm during chart review); (e) participants must be 
able to read and write in English. 
Exclusion criteria. (a) Potential secondary hypertension as supported by history 
of sleep apnea, renal artery disease, stenosis, certain cardiovascular diseases, 
hyperthyroidism, pregnancy, or adrenal gland tumor (pheochromocytoma) upon chart 
review by PI, (b) severe mental disorder that can hinder comprehension of instructions; 
(c) refusal to provide informed consent. 
Sample size estimation. The estimated sample size was based on multiple 
regression since both the dependent and independent variables are continuous.  Sample 
size was estimated through power analysis using G*Power (Faul, Erdfelder, Lang, & 
Buchner, 2007).  With an alpha level of .05, power of .80, small effect size of .07 (F2), 
and number of predictors as 10 (seven IR subscales plus theorized potential three 
subscales of the Cause section), the estimated sample size is 115.  Even though the 
estimated sample size is 115, the PI plans to recruit up to 150 respondents to compensate 
for missing data and to have a reasonable sample size for factor analysis as planned in 
this study. 
No software was identified that can be used to determine sample size for factor 
analysis. The developers of the IPQ-R questionnaire have recommended that factor 
analysis can be conducted using a sample size of 85 or more (Moss-Morris et al., 2003).  
However, some authors have recommended that a sample size of 150, or 10 cases per 
item to be analyzed, while others recommend a ratio of 5 cases per item (Pallant, 2007).  
A study that explored the association between illness perception and self-care behavior 





causal items of the IPQ-R using a sample of 111, so the present study will use any sample 
size close to 111 in conducting a factor analysis.  
To reach the indicated sample size, the PI estimates that about 500 potential 
participants may need to be approached and screened.  This is only an estimate since the 
PI will have no prior knowledge of how many patients in the clinic will meet inclusion 
criteria in this study considering that there will be no chart or record review before data 
collection.  Additionally, most of the clinics are not able to run an accurate report on their 
patient population to identify the number of patients that are likely to meet inclusion 
criteria.  However, to maximize the chance to recruit a meaningful number of participants 
on each recruitment day, the PI will ask the clinics to indicate which days and times 
many patients that are likely to meet inclusion criteria are scheduled, and the PI will be at 
the clinics on those days. 
Instruments. 
Illness Perception Questionnaire. Illness (hypertension) perception will be 
measured using the revised Illness Perception Questionnaire (IPQ-R), a scale that was 
developed to quantitatively assess patients’ perception of illnesses across a range of 
chronic diseases (Moss-Morris et al., 2002).  The questionnaire was developed using the 
constructs of the common-sense model as the theoretical framework.  The IPQ-R consists 
of two illness perception components, namely Illness Representation (IR) and Causes. 
The Identity component was not part of the revised IPQ-R, though it was only included 
for the purposes of psychometric testing (Moss-Morris et al., 2002). This study will 





    The IR component of the IPQ-R consists of 38 questions incorporated into seven 
subscales: Timeline (acute/chronic), Cyclical Timeline (episodic/temporary/ 
unpredictable), Treatment Control, Personal Control, Consequences, Illness Coherence, 
and Emotional Representations.  Timeline (acute/chronic), Consequences, Personal 
Control, and Emotional Representations are represented by six items on the 
questionnaire, respectively, while five items represent Treatment Control and Illness 
Coherence, respectively.  Finally, Cyclical Timeline is represented by four items on the 
questionnaire.  Each item is ranked on a Likert-type scale, with responses ranging from 1 
(strongly disagree) and 5 (strongly agree).  High scores on the respective subscales 
supports beliefs that hypertension is a chronic illness (Timeline), unpredictable/episodic 
(Cyclical Timeline), can severely impact quality of life (Consequences), and that it can be 
controlled by either personal behaviors (Personal Control) or by medical treatment 
(Treatment Control) (Moss-Morris et al., 2002).  The coherence subscale represents good 
personal understanding of the condition; thus, having a high score on a statement such as, 
“I have a clear picture or understanding of my high blood pressure,” indicates a good 
understanding of hypertension.  The score from each subscale is summed to get a total for 
the respective subscales. There is no overall total score for the IPQ-R. 
 The Cause component of the IPQ-R contains an additional 18 short items, which 
the developers recommend using as a grouping variable through factor analysis when 
there is sufficient sample size (85 or more) to identify the respective dimensions of 
perceptions of cause of an illness, after which the groups can be used as subscales in the 





The authors of the IPQ-R tested its validity using principal component analysis 
(PCA), where seven IR subscales were extracted, each with at least three factor loadings 
ranging from 0.5 to 0.86 (Moss-Morris et al., 2002).  The Cronbach’s alpha ranged from 
.79 to .89 for the IR subscales, and .67 to .86 for the causal items (Moss-Morris et al., 
2002).  Validity evidence was further explored by a study that aimed to examine the 
association between hypertension perception and self-care behavior among 111 Black 
hypertensive adults, 18 to 65 years, and reported Cronbach’s alphas ranging from .59 to 
.83 for the seven IR subscales, where Treatment Control had the lowest internal 
consistency (Cronbach’s alpha .59), followed by Personal Control (.63) and 
Consequences (.66) (Picket et al., 2014).  
The authors of the scale extracted three subscales from the 18 causal attribution 
items; which include (a) psychological factors, such as stress, and emotions; (b) risk 
factors, such as heredity, aging, poor medical care, and health behaviors; and (c) 
immunity, such as pollution, virus or altered immunity.  These three causal subscales had 
Cronbach’s alphas ranging from .67 to .86.  Additionally, the study by Picket et al. 
(2014), which used a sample of 111 African Americans, also extracted three causal 
attribution subscales with acceptable factor loadings, including (a) psychological factors 
(emotional state, mental attitude, personality, family problems, overwork, or aging); (b) 
uncontrollable factors, such as germs or viruses, pollution, chance or bad luck, altered 
immunity, or accidents; (c) biomedical explanation, such as personal behavior, diet or 
eating habit, stress or worry, or poor medical care.  The dimensions of causal attribution 





consistent with each other except for one item (“stress or worry”), which seemed to 
overlap between psychological and biomedical dimensions.  
The planned factor analysis in the present study would likely extracted similar 
dimensions.  Though the causal attribution subscales by Moss-Morris et al. (2002) 
demonstrated acceptable reliability with Cronbach’s alpha coefficients ranging from .67 
to .86, the sample was general population with respective medical illnesses.  However, 
Pickett et al (2014) used a sample of Black hypertensive adults and identified three 
meaningful causal subscales, but no reliability testing of these subscales was conducted.  
In the present study the PI will test the internal consistency reliability of the IR 
subscales and the causal attribution subscales.  For each subscale a Cronbach’s alpha 
coefficient of at least 0.70 will be considered acceptable evidence of reliability.  
However, subscales that have a Cronbach’s alpha less than .7, but not below .6, will be 
included in the final analysis, but the low internal consistency will be discussed as a 
weakness or limitation to the study’s finding as it relates to that particular subscale.  Any 
subscale with a reliability coefficient less than .6 will be eliminated, and the final analysis 
will be conducted without that subscale. 
Hill-Bone Blood Pressure Therapy Compliance Scale.  The dependent variable 
“medication adherence” will be measured using the Hill-Bone Compliance to High Blood 
Pressure Therapy Scale.  The questionnaire was designed to assess patient behaviors for 
three behavioral domains of high blood pressure therapy, including reduced sodium 
intake, appointment keeping, and medication adherence (Kim, Hill, Bone, & Levine, 
2000), however, only the medication subscale will be used in this study since the focus is 





of which eight items were related to questions about medication adherence; one 
prescription-filling adherence question is often used by researchers in addition to the 
eight medication-taking items.  The authors indicated that researchers interested in 
measuring medication adherence should use the medication-taking subscale alone.  Each 
item on the scale is a four-point Likert type scale (“4” equals “all the time” and “1” 
equals “none of the time”).  The lower the scores, the better the patient’s adherence level.  
According to the authors, the items are assumed to be additive; thus, when summed, a 
score of nine on the medication adherence subscale represents “perfect adherence” while 
a score of 36 denotes “perfect non-adherence.”    
Validity of the questionnaire was established through two studies: one that 
utilized 309 hypertensive Black males 18 to 55 years old and another with 718 Black 
hypertensive adults 18 years and older; these studies’ Cronbach’s alpha coefficients were 
.74 and .85 for the total scale, respectively (Kim et al., 2000).  In addition, a study with a 
sample of 80 Black women assessing the relationship between spirituality and medication 
adherence reported a Cronbach’s alpha of .843 for the medication adherence subscale 
(Abel & Greer, 2017).  A study with a sample of 190 urban Black men reported a 
Crobanch’s alpha of .77 for the medication adherence subscale of the questionnaire (Kim, 
Han, Hill, Rose, & Roary, 2003).  Eight experts confirmed the content validity of the 
scale; additionally, construct validity through PCA using varimax rotation extracted three 
subscales, though factor loading in both study 1 and 2 showed that the medication-
adherence subscale possessed the most meaningful loadings.  Predictive validity showed 
that the summed scores of each subscale correlated with blood pressure level and control 





  Demographic data and confounding variables form.  A short questionnaire will 
be designed to collect demographic data including age, gender, health insurance, and 
employment status.  The demographic data form will also be used to collect data about 
covariate or confounding variables anticipated to impact both illness perceptions and 
medication adherence, including duration of hypertension diagnosis, educational level, 
experience of hypertension-related symptoms, severity of hypertension, and history of 
depression (comorbidity) diagnosed by a healthcare provider.  Educational level will be 
operationally categorized into four levels: “less than high school,” “high school,” “some 
college or trade school,” and “four-year college or greater.”  Gender will be categorized 
into two options, “male” or “female.” Participants will be asked to state how long they 
have been diagnosed with hypertension.  Severity of hypertension will be categorized 
into two levels based on blood pressure classification by the Joint National Committee on 
Prevention, Detection, Evaluation and Treatment of Hypertension ([JNC], 2003): stage 1 
= 140-159/90-99; stage 2 = ≥160/≥100, where stage 1 will represent mild hypertension, 
and stage 2 will represent severe hypertension. The average of the past two blood 
pressure readings will be taken to decide on the severity of blood pressure.  Symptoms of 
hypertension will be categorized as “yes (present)” or “no (absent).” In addition, chart 
review will be conducted to verify information about demographic characteristics and 
confounders. 
Procedures for data collection. Questionnaires that will be completed include 
the 56-item Illness Perception Questionnaire, the nine-item Hill-Bone medication 
adherence questionnaire, and a short (10 items) demographic questionnaire, for a total of 





Data collection from the four clinics will occur in person, where the principal 
investigator (PI) will recruit participants as they come to their regularly scheduled 
appointments with their healthcare providers.  Every adult patient of African ancestral 
origin waiting to see their healthcare providers in the lobby or waiting area of the clinics 
to see their healthcare providers, will be approached by the PI with the recruitment flyer. 
Those who indicate interest, meet inclusion criteria, and give informed consent, will be 
given the questionnaires to complete.  Each completed questionnaire will be assigned a 
study identification number.  
In addition, recruitment flyers will be placed in the clinics’ lobbies or waiting 
areas as well as exam rooms, so that patients whose doctors’ appointments occur when 
the PI is not present at the clinics can still contact the PI for participation if interested.  
The recruitment flyer will contain information about the purpose of the study, inclusion 
criteria, and procedure, as well as the PI’s contact information.  The consent form will 
contain the purpose of the study, benefit, risks, and confidentiality, as well as the PI’s 
contact information.   
Any participant who contacts the PI over the phone and indicates interest in 
participation, will be scheduled to meet with the PI at the clinic during their next 
scheduled appointment at the clinic for completion of the questionnaires and consent 
forms.  Understandably, there may be a chance that it may not be feasible for the PI to 
meet with these patients since their next appointment could be in another three months.  
Even though patients with chronic illnesses such as hypertension are usually seen by their 
healthcare providers every three to six months, the frequency of visits is often determined 





needs of the patient.  These potential participants may have additional visits to the clinics 
for other medical needs since these are their medical homes. 
 Privacy will be maintained while interacting with the potential participants in the 
lobby, and neither the PI nor the participants will engage in any discussion pertaining to a 
sensitive or private issue in the lobby.  Each participant will receive a Walmart or 
Starbucks gift card worth $15 at the completion of the questionnaires.   
Chart review will be conducted to confirm diagnosis of primary or essential 
hypertension, duration of hypertension diagnosis, history of depression, and blood pressure 
reading after the participants have signed consent forms and completed the questionnaires.  
To conduct chart review, each participant will be asked for their name and date of birth, 
which will be written on a separate paper with the respondents’ study identification 
numbers.  This information will only be needed to identify the respective charts for review 
on the day the questionnaires are completed and will be shredded before the PI leaves the 
clinic.  After chart review, the participants’ completed questionnaires will only retain the 
respective study identification numbers, and no other form of identifier will be attached to 
the completed questionnaires.  During chart review, the electronic medical record (EMR) 
for the clinics that are using EMR usually will record patients’ hypertension diagnosis as 
primary/essential or secondary. When not sure, merely clicking on the diagnosis 
(hypertension) from the list of patients’ diagnoses will reveal the ICD-10 (I10) code for 
essential/primary hypertension.  For clinics using paper charts, in the absence of other 
disease that could cause elevated blood pressure, the handwritten diagnosis of 






Data analysis. All data analysis will be conducted using SPSS software, version 
23.  Descriptive statistics will be conducted to explore characteristics of the sample.  
Respective descriptive statistics will be conducted to explore distributions for the 
continuous independent variables as well as the frequency of the categorical outcome 
variables.  In addition, a univariable analysis will be conducted to check for association 
between medication adherence and each of the predictor (illness perceptions) variables.  
Reliability testing will be conducted to check for the reliability of the IPQ-R subscales 
(IR and Cause subscales) for the current sample.  Factor analysis of the causal items will 
be conducted first to identify the causal attribution subscales; then these subscales will be 
used in combination with other IPQ-R (IR) subscales to conduct the multiple regression 
for Aim #2.  Multiple regression will be conducted to check whether all or some the IPQ-
R subscales predict medication adherence while controlling for covariates.  
Aims, hypotheses, and statistical testing. 
Aim #1: To explore participants’ perceptions about the cause of hypertension. 
Hypothesis #1: Among other factors, perception of psychological factors as cause of 
hypertension will explain the highest variance in views about the cause of hypertension. 
Statistical Analysis for Aim #1: Factor analysis will be conducted using the 18 cause 
perception items of the IPQ-R. Exploratory factor analysis with varimax rotation will be 
conducted to decipher the cluster of views about the cause of the sample’s hypertension. 
Factors with acceptable factor loadings will be selected and defined.  The decision to 
assign an item to a factor will based on a priori setting of greater than or equal to .40 for 
factor loadings and less than or equal to .20 for cross-loadings (Ferguson & Cox, 1993).  





2006).  Previous studies have identified three meaningful causal attribution factors using 
the IPQ-R scale (Moss-Morris et al., 2003; Pickett et al., 2014).   
 Aim #2: To examine the relationship between medication adherence and perceptions 
about hypertension timeline, controllability, consequences, emotional representation, 
illness coherence, and cause among Black hypertensive adults 35 to 65 years old, while 
controlling for depression, educational level, age, duration of hypertension diagnosis, 
experience of hypertension-related symptom, and severity of hypertension.  
Hypothesis #2: There will be a statistically significant positive relationship between 
medication adherence and hypertension perceptions, where high scores on the subscales 
of the IPQ-R will be associated with better medication adherence scores. 
Statistical Analysis for Aim#2: Multiple regression analysis will be conducted to 
determine whether IPQ-R subscales (Timeline [acute/chronic], Cyclical Timeline 
[episodic], Personal Control, Treatment Control, Consequences, Emotional 
Representation, Illness Coherence, and Cause) will predict medication adherence while 
controlling for the confounders (hypertension-related symptoms, severity of 
hypertension, depression, age, educational level, and duration of hypertension diagnosis).  
All potential confounding variables will be included in the initial model, and 
nonsignificant ones will be eliminated one at a time, starting with the highest p-value. 
Only significant confounders (p < .05) will be retained. 
Aim #3: To explore to what extent hypertension perceptions and medication adherence 
differ by gender while controlling for confounders. 
Statistical Analysis for Aim #3(a):  Since illness perception is continuous variable while 





explore gender differences in each of the hypertension perceptions subscales. 
Confounders that will be controlled for include educational level, age, and duration of 
hypertension diagnosis. 
Statistical Analysis for Aim #3(b):  A second ANCOVA will be conducted to explore to 
what extent medication adherence differs by gender after controlling for age, number of 
medications, educational level, and comorbidity (depression). 
Limitations.  Misclassification of medication adherence or illness perceptions 
may be one of the limitations of this study due to the use of self-report questionnaires to 
measure these variables.  Self-report questionnaires may lead to participants’ 
overestimation of adherence, recall bias, and likelihood for giving socially acceptable 
responses (Morisky et al., 2008).  Additionally, data collection will involve use of long 
self-report questionnaires, which may lead to a high rate of missing data, however, the 
sentences are short, easy to understand, and the questionnaire takes less than 20 minutes 
to complete.  The PI will review the completed questionnaires at time of completion, and 
each participant will be asked to complete any missing data. 
  Another limitation of this study is that cause and effect cannot be established with 
cross-sectional study designs.  Conducting factor analysis with a small sample size may 
also cause the factor structures to be unreliable (Pallant, 2007).  One major problem with 
the proposed procedures is the inability to recruit the estimated sample size; however, the 
chance for this problem is reduced since recruitment will occur in several clinics.  
Despite these limitations, there is value in the knowledge to be gained and the results will 





  Another important limitation is the inability to address the impact of acculturation 
on hypertension perceptions, specifically in terms of the duration a foreign-born 
participant may have lived in the US.  However, the current study’s focus is not strictly 
on a foreign-born sample of hypertensive population. Future study in this area could 
focus on exploring the association between hypertension perceptions and acculturation 
among foreign-born hypertensive Black adults residing in the US.  
Human Subjects 
Approval to conduct this study will be obtained from the University of Texas 
Health Science Center - Houston Institutional Review Board (IRB).  Health Insurance 
Portability and Accountability Act (HIPPA) guidelines will be maintained throughout the 
process.  Consent will be obtained from participants for participation and chart review.  
Permission for recruitment will be obtained from each recruitment sites.  All signed 
consent forms will be separated from the completed questionnaires and stored in a 
different folder in a locked cabinet.  The PI will not leave the clinics with any patient-
identifying data from participants’ charts.  No date of birth or name will be recorded on 
the completed questionnaires; however, the PI will collect participants’ names and date of 
birth for chart review; in addition, the HIPPA consent forms will also contain the 
participants’ names and signature.  Any identifier collected from the participants to 
identify their records for chart review will be shredded in the clinic before the PI departs 
on each recruitment day.  In general, there is minimal risk involved in this study. This 
study is not anticipated to infringe on participants’ rights or cause any harm.  
One of the risks that could be associated with this study is breach of 





to each participant, and data from completed questionnaires will not be linked to with any 
personal identifiers.  Confidentiality will be strictly protected to the extent allowable by 
law.  The principal investigator, dissertation chair, and statistician will have access to 
questionnaire data or survey responses, and these data will be completely de-identified; 
thus, participation in the study will not affect participants’ care at the clinics. 
No patient-identifying information will be included in any publication of the 
study. Questionnaires and consent forms will be stored in separate folders in a locked 
cabinet and will be shredded one year after the study is completed.  
Another risk is the discomfort that may originate from having to complete several 
questionnaires with a total of 75 items, however, the sentences are short and easy to 
understand.  Participants will be assured they can take a break or stop the questionnaire at 
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Association of Hypertension Perceptions and Antihypertensive Medication Adherence 
Among Black Hypertensive Adults in Primary Care Settings. 
Stella Eke, DNP, RN, FNP-C 
 
Introduction 
Hypertension (HTN) is the leading cause of most cardiovascular diseases 
(Valderrama, Gillespie & Mercado, 2013).  Among non-Hispanic Blacks aged 20 years 
and older, 45% of males and 46.3% of females have hypertension, compared to 34.5% for 
White males and 32.3% for White females (American Heart Association [AHA], 2017a).  
Uncontrolled hypertension is considered an important risk factor for coronary heart 
disease, stroke, congestive heart failure, end-stage renal disease, and peripheral vascular 
disease (AHA, 2017b; Sulainman et al., 2009).  Compared with Whites, Blacks develop 
hypertension at an earlier age, have higher average blood pressure, and poorer blood 
pressure control, leading to Blacks with hypertension having 1.3 times greater rate of 
nonfatal stroke, 1.8 times greater rate of fatal stroke, 1.5 times greater rate of heart 
disease death, 4.2 times greater rate of end-stage kidney disease, and 50% higher 
frequency of heart failure (AHA, 2015; Go et al., 2014).  
Although 80.8% of Blacks are aware of their hypertension, with 71.9% under 
treatment, only 36.9 % have their hypertension under control; meanwhile, 79.1% of 
Whites are aware of their hypertension, with 73.9% under treatment, and 42.9% have 





more likely to be non-adherent to antihypertensive medications and more likely to have 
uncontrolled hypertension than other races (Redmond, Baer, & Hicks, 2011; Dickinson & 
Plauschinat, 2008; Bosworth et al., 2006).  Shaya et al. (2009) examined predictors of 
antihypertensive therapy adherence among 568 Medicaid hypertensive patients and found 
that Blacks were 50% less adherent to medication compared to their White counterparts.  
Furthermore, a longitudinal cohort study among hypertensive Medicaid recipients found 
that African American patients were less adherent to medications than Whites (55% vs. 
61%, p < .05) (Dickson & Plauschinat, 2008).  Non-Hispanic Blacks had 90% higher 
odds of poorly controlled hypertension compared to non-Hispanic Whites, even after 
controlling for socioeconomic status, gender, age, and other clinical factors, such as 
smoking status, sodium intake, and alcohol (Redmond, Baer & Hicks, 2011).   
Even with the advancement over the years in treatment options for hypertension 
and other cardiovascular disease risk factors, uncontrolled hypertension remains a public 
health burden in the United States (Mozaffana et al., 2015; Chobanian, 2015).  
Furthermore, Chobanian (2015) asserts that evidence has shown that the new and 
advanced antihypertensive medication options have been shown to be effective in 
controlling hypertension in anyone, irrespective of race. 
Better understanding of the critical factors impeding medication adherence and 
blood pressure control among Black hypertensive adults will inform the design and 
implementation of meaningful interventions to curtail the alarming burden of 
uncontrolled hypertension among the Black adult population.  Factors affecting 
medication adherence among Black hypertensive adults seem to be multifaceted.  A 





impact medication adherence among Blacks, including healthcare system, nature of 
hypertension as an often-non-symptomatic disease, treatment complexity, presence of 
other comorbidities, and patient-related issues.  
 Many qualitative studies have reported that Black adults have misconceptions 
about hypertension (Ogedegbe, Mancuso, & Allegrante, 2004; Lukoschek, 2003; Wilson 
et al., 2002), but only a few studies have examined the relationship between these 
misconceptions and medication adherence (Heckler et al., 2008; Heurtin-Roberts & 
Resisin, 1990).  There is a need to have a better understanding of perceptions about 
hypertension held by Black hypertensive adults and the extent to which these perceptions 
impact medication adherence. The current study focuses on Black hypertensive adults 
aged 35 to 65 years because this is the age group that has a high incidence and prevalence 
of hypertension among Black adults.  Although individuals start developing hypertension 
around middle age, Blacks develop hypertension at an even younger age on average 
(CDC, 2016; AHA, 2016). 
The first objective of this study was to investigate perceptions of causal 
attributions of hypertension among Black hypertensive adults. The second but primary 
objective of the current study was to examine whether there is an association between 
hypertension perceptions and medication adherence among Black hypertensive adults 35 
to 65 years of age in primary care settings, after controlling for the effects of certain 
confounders that could also impact hypertension perceptions and medication adherence.  
Because most of the existing knowledge about hypertension perceptions among Black 





explore whether there were gender differences in hypertension perceptions and 
medication adherence.  
Background 
 The World Health Organization ([WHO], 2003) defines medication adherence as 
the extent to which a patient’s medication-taking behavior matches with agreed 
recommendations from a healthcare provider.  Medication adherence is further defined as 
the degree to which a patient follows recommended advice or takes medications with the 
timing, dosing, and frequency prescribed by their healthcare providers (Cramer et al., 
2008).  According to the WHO (2003), the patient should be considered an active 
collaborator in their treatment rather than a passive recipient of advice from healthcare 
providers. 
The poor medication adherence and hypertension control among Black 
hypertensive adults have placed a high burden of morbidity and mortality associated with 
hypertension on this population as well as posed a serious public health burden.  A 30-
year mortality risk among White hypertensive men was 23.8%, compared to 45.2% for 
Black hypertensive men, and 18.3% for White women, compared to 39.5% for Black 
women (Lackland, 2014).  According to the Agency for Healthcare Research and Quality 
([AHRQ], 2013), in 2010, direct medical expenditure for hypertension totaled 42.9 
billion, with a higher percentage of non-Hispanic Blacks (30.4%) being treated for 
hypertension than non-Hispanic Whites (26.7%); furthermore, annual expenditure for 
those treated for hypertension averaged $733 per adult, while mean expenditure per 
person with hypertension was $887 for Blacks compared to $679 per person for non-





increase from $69.9 billion in 2010 to $200.3 billion in 2030 (Heidenreich, 2011), while 
the Center for Disease Control and Prevention ([CDC], 2016) reports that hypertension 
costs $48.6 billion yearly. 
 As noted earlier, the reason for medication non-adherence and poor blood 
pressure control among Blacks seems complex and multifaceted.  Individual studies have 
outlined factors such as poor socioeconomic status, distrust for physicians, racial 
discrimination, comorbidities, disease-related problems (such as absence or presence of 
symptoms), complexity of medication regimen, patient-provider communication, 
depression, and a fatalistic view of hypertension (Greer, 2010; Ndumele et al., 2010; 
Ogedegbe et al., 2003; Ogedegbe et al., 2004).  Additionally, a recent study with a 
majority-Black-hypertensive-adult sample noted that patient-provider interaction that 
does not involve the patient or involve patients’ sociodemographic needs often leads to 
poor medication adherence (Schoenthaler, Knafl, Fiscella, & Ogedegbe, 2017).  The 
systematic review by Lewis (2012) on factors affecting medication adherence among 
Black hypertensive adults reported that non-adherence was consistently associated with 
self-efficacy; depression; patient-provider communication and system-related factors; 
disease-related factors, such as presence or absence of symptoms; and severity of 
hypertension.  
Although the poor medication adherence and blood pressure control among Black 
hypertensive adults have been attributed to numerous factors, the solution to the problem 
remains difficult and elusive (Kressin, Orner, Manze, Glickman, & Berlowitz, 2010).  





inconclusive or non-promising results; thus, the need to explore other potential 
contributing factors, such as illness perception. 
Illness perception is conceptually defined as an individual’s beliefs or cognitive 
understanding about an illness (Leventhal et al., 2003).  A deeper understanding of illness 
perception has been shown to be useful in assessing patients’ illness outcomes (Figueiras 
& Alves, 2007; Hagger & Orbell, 2003).  When faced by a health threat, an individual 
cognitively evaluates and tries to make sense of the health threat, after which the 
individual is likely to develop a coping mechanism that is guided by the level of risk 
perceived about the illness.  These beliefs can be shaped by medical knowledge through 
interaction with healthcare providers, personal experiences, and/or experiences of others, 
such as family or friends (Petrie & Weinman, 2006).  An individual who holds a 
misguided perception or understanding about the cause, complications, timeline, 
controllability/cure, and chronicity of hypertension is likely to be non-adherent to 
prescribed medications.  
Middleton (2009) suggested that the lower rates of adherence to prescribed 
therapy for hypertension, including exercise, diet, and medication among Black 
hypertensive adults may be related to the inaccurate illness perceptions held about 
hypertension that are not consistent with a biomedical disease model of hypertension.  
Ross et al. (2004) discussed the effect of illness beliefs on predicting medication 
adherence, and further reported that patients who do not perceive hypertension to be 
serious may self-regulate their antihypertensive medications accordingly.  The authors 
further suggested that targeting patients’ health beliefs may be important in designing 





a sample of 19 African-American, 20 White, and nine Hispanic Veterans Administration 
patients, reported that among other factors, patients’ perceptions of the cause, course of 
hypertension, and experiences of hypertension symptoms were linked with their reports 
of their self-management behaviors (Bokhour et al., 2012).  A quantitative study by 
Rajpura and Nayak (2014), with a sample that was made up of 76.9% Whites and 18.8% 
Blacks aged 55 years and older reported that more favorable perceptions of illness were 
associated with higher medication adherence scores (p = .001).   
Conceptual framework.  The self-regulation of health and illness model, also 
known as the common-sense model (Leventhal, Brissette, & Leventhal, 2003) served as 
the theoretical guiding framework for the present study.  This model emphasizes the role 
of illness perception in guiding coping behaviors toward an illness, which subsequently 
affect illness outcomes.  The model proposes that in response to a health threat, 
individuals may develop both parallel cognitive and emotional representations, which in 
turn gives rise to problem-based and emotional-focused coping behaviors (Leventhal et 
al., 2001).  The authors proposed that response to illness involves three processes, namely 
representation, coping, and appraisal.  
The model posits that the mental impressions patients attach to the identity 
(symptoms), duration of illness, illness outcome/consequences, causal factors, and 
control/curability guide their coping mechanism toward the illness.  When faced with a 
health threat, the individual tries to develop a cognitively-reasoned understanding of the 
health threat, eventually develops a coping mechanism based on personal mental 
representation of the illness, and, finally, with time, appraises such coping mechanisms.  





wrongly perceives an illness such as hypertension to be non-life threatening or a disease 
without consequences (complications), adherence to medication may be low.  
The model identifies five constructs of illness representation as follows (Leventhal et 
al., 2003), namely: (a) Identity/Label (Symptoms); (b) Timeline; (c) Consequences; (d) 
Cause; and (e) Control/Cure.  Identity represents the label a patient assigns to personal 
symptoms or perception of symptoms associated with the illness.  Timeline represents the 
patient’s perception of the duration of the illness in terms of whether the illness is 
acute/temporary, chronic, or cyclical in nature.  Consequence signifies the level of threat 
or complications perceived to be associated with the illness.  Cause represents perceived 
etiology of the illness as it relates to external or internal factors or stressors.  Finally, 
Control or Cure represents what the individual thinks about the controllability or 
curability of the illness by medication, and/or whether they can do what is needed to 
control the disease.  
Most patients with high blood pressure often misconceive the disease as a non-life-
threatening illness, especially due to its mostly asymptomatic nature.  A misguided view 
of hypertension may lead to non-adherence behavior with prescribed medication.  This is 
particularly important among Black adults as studies have reported that most Blacks 
attribute the cause of hypertension to stress or other psychologically-based factors and 
often engage in stress-management activities to control hypertension at the expense of 
medications (Heckler et al., 2008; Heurtin-Roberts, 1990; Rose, Kim, Dennison, & Hill, 
2000; Wilson et al., 2002).  
The asymptomatic nature of hypertension has led some patients to question their 





Schmitke, 2007).  Some patients with hypertension often adjust their medication based on 
symptoms, which may be very deceiving since lack of symptoms does not necessarily 
indicate the absence of elevated blood pressure or hypertension (Schlomann, & Schmitke, 
2007); thus hypertension is called a silent killer. 
The literature search revealed that only a few studies have examined the 
relationship between perceptions of hypertension and medication adherence among Black 
hypertensive adults.  An older study by Heurtin-Roberts and Reisin (1992) assessed the 
relationship between lay beliefs about hypertension and medication adherence among 60 
Black hypertensive women attending a public-hospital-based clinic in New Orleans using 
field notes, medication diaries, and pill count. Participants who perceived the cause of 
hypertension within the non-biomedical model were more likely to be non-adherent with 
their medications compared to those who had biomedical views of hypertension (relative 
risk = 2.3; 95% CI [1.2-4.4]).  Heckler et al. (2008) carried out the most recent study on 
the impact of perception or common-sense illness beliefs on therapy adherence among 
102 Black adult hypertensive patients.  This study found that perception of stress as the 
cause of hypertension correlated (r = .34, df = 100, p < .01) with engaging in stress-
reducing behaviors to manage high blood pressure at the expense of medication and 
lifestyle modifications, while beliefs in the biomedical model of hypertension weakly 
correlated with medication adherence and lifestyle modifications to control high blood 
pressure (r = - .21, df = 100, p < .05). 
Some intervention studies with sample sizes ranging from 55 to 1,059, did not 
directly target hypertension perceptions, instead aiming at improving understanding of 





Black hypertensive adults; these studies have reported mostly non-significant differences 
in blood pressure control or reduction between the intervention and control groups from 
baseline to follow-up (Greer et al., 2015; Ogedegbe et al., 2008; Johnson et al., 2011; 
Roberts et al., 2012; Ogedegbe et al., 2014; Webb, 1980).   
There is an obvious gap in knowledge; though qualitative studies have elicited 
various levels of misconception about hypertension among Black adults, there are very 
few quantitative studies investigating the relationship between perceptions about 
hypertension and medication adherence.  As discussed earlier, the most recent study that 
explored the association between hypertension perception and medication adherence 
among Black hypertensive adults was in 2008. 
To address this gap in knowledge, the central aim of the present study was to 
investigate whether there is an association between hypertension perceptions and 
medication adherence among Black hypertensive adults 35 to 65 years old being treated 
for hypertension in primary care settings.  Specifically, the purposes of this study were to: 
1. Investigate participants’ perceptions about causes of hypertension.  It was 
hypothesized that, compared to other factors, perceptions of psychological factors 
as the cause of hypertension will explain the highest variance in views about the 
cause of hypertension. 
2. Examine the relationship between medication adherence and hypertension 
perceptions as related to views about hypertension timeline, controllability, 
consequences, emotional representation, illness coherence, and cause while 
controlling for depression, educational level, duration of diagnosis, hypertension-





will be a statistically significant relationship between perceptions of hypertension 
and medication adherence. 
3. Explore to what extent hypertension perceptions and medication adherence differ 
by gender after controlling for confounders. 
Methods 
Design, setting, and sample.  This was an observational cross-sectional research 
study that used a non-probability sampling method to recruit participants.  Participants 
were recruited concurrently from four primary care clinics in the Houston, Texas 
metropolitan area.  One of the clinics was an employee health clinic affiliated with a 
university.  Thirty-nine percent (n = 46) of the participants were recruited from one 
clinic, followed by another 29.7% (n = 35) from the second clinic, and 26.3% (n = 31) 
from the third clinic.  Enrollment from the fourth clinic, which was the employee health 
clinic, was the lowest (5.1%, n = 6). 
Inclusion criteria. The sample inclusion criteria were:  (a) self-identified Black 
adults; (b) males and females, aged 35 to 65 years;  (c) diagnosis of primary/essential 
hypertension (diagnosis of essential hypertension was confirmed by the principal 
investigator [PI] during chart review, based on noting a written diagnosis of “essential” or 
“primary” hypertension or an ICD 10 code (I10) in patients’ charts); (d) duration of 
hypertension diagnosis of at least 12 months; (e) had been prescribed or was taking at 
least one hypertensive medication; (e)  ability to read and write in English. 
Exclusion criteria. The exclusion criteria were: (a) secondary hypertension as 
supported by history of sleep apnea, renal artery disease, stenosis, certain cardiovascular 





chart review; (b) severe mental disorder hindering comprehension of instructions; and (c) 
refusal to provide informed consent. 
Sample size estimate.  Power analysis estimated sample size at 115 based on 
power of .80, alpha of .05, and effect size of .07 using multiple regression. The primary 
purpose of this study was to examine the relationship between illness perception and 
medication adherence. 
Instruments for data collection.  Two validated questionnaires in addition to a 
demographic data form were used in data collection.  Participants completed the revised 
Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al., 2003) and the Hill-Bone 
Blood Pressure Therapy Compliance Scale (Kim et al., 2000). 
Illness Perception Questionnaire.  Illness (hypertension) perception was 
measured using the revised Illness Perception Questionnaire (IPQ-R), a scale that was 
developed to quantitatively assess patients’ perception of illnesses across a range of 
chronic diseases (Moss-Morris et al., 2002).  The questionnaire was developed using the 
constructs of the common-sense model as the theoretical framework.  The IPQ-R consists 
of two illness perception components, namely: Illness Representation (IR) and Causes. 
The Identity component was not part of the revised IPQ-R, though it was only included 
for the purposes of psychometric testing (Moss-Morris et al., 2002). In this study, 
participants completed the hypertension version of this scale. 
    The IR component of the IPQ-R consists of 38 questions incorporated into seven 
subscales, namely Timeline (acute/chronic), Cyclical Timeline 
(episodic/temporary/unpredictable), Treatment Control, Personal Control, Consequences, 





Consequences, Personal Control, and Emotional Representations are represented by six 
items on the questionnaire, while five items represent Treatment Control and Illness 
Coherence.  Finally, Cyclical Timeline is represented by four items on the questionnaire.  
Each item is ranked on a Likert-type scale, with responses ranging from 1 (strongly 
disagree) to 5 (strongly agree). High scores on the respective subscales supports beliefs 
that hypertension is a chronic illness (Timeline), unpredictable/episodic (Cyclical 
Timeline), can severely impact quality of life (Consequences), and that it can be 
controlled by either personal behaviors (Personal Control) or by medical treatment 
(Treatment Control) (Moss-Morris et al., 2002).  The Coherence subscale represents good 
personal understanding of the condition; thus, having a high score on a statement such as, 
“I have a clear picture or understanding of my high blood pressure,” indicates a good 
understanding of hypertension.  The score from each subscale is summed to get a total 
score for the respective subscales. The higher the score, the stronger the beliefs or views 
about that dimension. There is no overall total score for the IPQ-R. 
 The Cause component of the IPQ-R contains an additional 18 short items, which 
the developers recommend be used as a grouping variable through factor analysis when 
there is sufficient sample size (85 or more) to identify the respective dimensions of 
perception of cause of an illness, after which the groups can be used as subscales in the 
analysis (Moss-Morris et al., 2002). 
The validity of the IPQ-R was demonstrated through principal component 
analysis, through which seven IR subscales and three causal attribution factors were 
identified (Moss-Morris et al., 2002).  The Cronbach’s alpha ranged from .79 to .89 for 





was further tested by a study that examined the association between hypertension 
perception and self-care behavior among 111 Black hypertensive adults, 18 to 65 years, 
and a reported Cronbach’s alpha ranging from .59 to .83 for the seven IR subscales, 
where Treatment Control had the lowest internal consistency (Cronbach’s alpha .59), 
followed by Personal Control (.63) and Consequences (.66) (Pickett et al., 2014).  
Hill-Bone Blood Pressure Therapy Compliance Scale.  The dependent variable 
“medication adherence” was measured using the Hill-Bone Compliance to High Blood 
Pressure Therapy Scale.  The questionnaire was designed to assess patient behaviors for 
three behavioral domains of high blood pressure therapy, including reduced sodium 
intake, appointment keeping, and medication adherence (Kim, Hill, Bone, & Levine, 
2000); however, only the medication subscale was used in this study since the focus was 
on medication adherence.  The total scale contains 14 items, grouped into three subscales, 
of which eight items were related to questions about medication adherence; additionally, 
one prescription-filling adherence question is often used together with the eight 
medication-taking items by researchers.  Each item on the scale is a four-point Likert 
type scale (“4” equals “all the time” and “1” equals “none of the time”).  The lower the 
scores, the better the patient’s adherence level.  According to the authors, the items are 
assumed to be additive and when summed; thus, a score of nine on the medication 
adherence subscale represents “perfect adherence” while a score of 36 denotes “perfect 
non-adherence.”    
Validity of the questionnaire was established through two studies: one utilized a 
sample of 309 hypertensive Black males 18 to 55years old, while the other study used 





alpha coefficients were .74 and .85 for the total (Kim et al., 2000).  In addition, a study 
with a sample of 80 Black women assessing the relationship between spirituality and 
medication adherence reported a Cronbach’s alpha of .843 for the medication-adherence 
subscale (Abel & Greer, 2017).  A study with a sample of 190 urban Black men reported 
a Crobanch’s alpha of .77 for the medication-adherence subscale of the questionnaire 
(Kim, Han, Hill, Rose, & Roary, 2003).  Validity through PCA using varimax rotation 
extracted three subscales, though factor loading in both study 1 and 2 showed that the 
medication-adherence subscale possessed the most meaningful and acceptable factor 
loadings.  Predictive validity showed that the summed scores of each subscale correlated 
with blood pressure level and control (Kim et al., 2000). 
Evidence of instruments reliability in present study. Reliability testing was 
conducted to evaluate evidence of internal consistency of the IPQ-R subscales and the 
Hill-Bone Blood Pressure Therapy Adherence Scale for the present study.  After reverse 
coding the negatively worded items on the IPQ-R questionnaire as recommended by the 
developer (Moss-Morris et al., 2002), total scores were calculated for each of the seven 
subscales of the IR in addition to the two subscales extracted from the causal attribution 
items, making the total subscales from the IPQ-R questionnaire nine.  Each of these 
subscales was subjected to a reliability testing.  Most of the subscales demonstrated 
strong evidence of internal consistency reliability with a Cronbach’s alpha greater than .7 
(Timeline =.86, Cyclical Timeline = .83, Consequences = .79, Illness Coherence = .83, 
Emotional Representation = .83, Non-Biological Causal Views = .78, Psycho-Biological 
Causal Views = .75). Two subscales that had slightly lower internal consistency were 





.66, respectively.  These two subscales had the lowest internal consistency (Personal 
Control = .63, Treatment Control = .59) in another study (Pickett et al., 2014). 
Reliability testing of the Hill-Bone Medication Adherence Scale showed the 
instrument demonstrated a strong internal consistency with a Cronbach’s alpha of .82.  A 
Cronbach’s alpha greater than .70 is acceptable evidence of reliability (Leech, Barrett, & 
Morgan, 2015; Pallant, 2007). 
Demographic data and confounding variables form.  A short questionnaire was 
designed to collect demographic data including age, educational level, health insurance, 
and employment status.  The demographic data form was also used to collect data about 
covariate or confounding variables anticipated to impact both illness perceptions and 
medication adherence, including duration of hypertension diagnosis, educational level, 
experiencing worrisome hypertension-related symptoms (yes or no responses), number of 
blood pressure medications, severity of hypertension, and history of depression 
(comorbidity) diagnosed by a healthcare provider.  History of depression was based on a 
“yes or no” responses as well as verified through chart review and noting prescribed 
depression medications.  Severity of hypertension was categorized into two stages based 
on blood pressure classification by the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of Hypertension ([JNC], 2003): stage 1 = 140-
159/90-99 and stage 2 =≥ 160/≥100, where stage 1 represents mild hypertension, and 
stage 2 represents severe hypertension.  For the purposes of this study, blood pressure 
readings below 140/90 were considered normal, thus creating a third category in this 
study.  Blood pressure readings recorded in each participants’ chart during two separate 





blood pressure readings or doctors’ visits were generally three months apart.  For most of 
the participants, the two blood pressure measurements used were from the readings in the 
chart on the day of data collection and the readings from the prior visit, three months 
before. 
Procedures.  Participants were approached in the clinics’ lobbies by the PI with 
the recruitment flyer as they presented for their regular medical appointments with their 
healthcare providers.  Furthermore, the PI verbally explained the study and allowed each 
participant time to ask questions.  Individuals who agreed to participate were asked to 
complete the questionnaires after signing consent.  The questionnaires were mostly self-
administered; three to four participants asked their accompanying family members or the 
PI to read the questions and response options to them while they verbally indicated which 
options they chose.  Each participant received a $15 gift card upon completion of the 
questionnaires.  A chart review was conducted at the end of each recruitment day to 
gather information about the number of medications participants were taking for their 
blood pressure, blood pressure readings, duration of hypertension, and any documented 
history of depression, as these data served as covariates in the analyses.  Additionally, 
diagnosis of essential or primary hypertension or presence of secondary hypertension 
were confirmed through chart review.  Most of the data on the duration of hypertension 
was based on the participants’ report since patients’ medical records do not often have the 
most reliable information about when the patient was diagnosed with hypertension, 
unless the diagnosis was initially established at that clinic.  The PI is an experienced 
family nurse practitioner in active practice, thus possessing the clinical knowledge to 





codes, and class of medications used for hypertension and/or other cardiac conditions as 
well as for depression and/or other mental health disorders. 
Statistical analyses.  All data analyses were conducted using IBM’s Statistical 
Package for Social Sciences (SPSS) software, version 24.  The sociodemographic 
characteristics of the sample and distributions of the continuous variables were examined 
with descriptive statistics.  Univariable analyses were conducted to check for associations 
of medication adherence with each of the predictor (illness perceptions subscales) 
variables and potential confounding variables.  Reliability testing was conducted to 
examine the internal consistency of the IPQ-R subscales (IR and Cause subscales) for the 
current sample as well as for the outcome variable (medication adherence).  
To address the first aim of this study, a principal component factor analysis with 
varimax rotation was conducted using the 18 causal items of the IPQ-R to identify the 
sample’s causal attribution dimensions, after which the extracted subscales were used in 
combination with other IPQ-R (IR) subscales to conduct the multiple regression analysis 
in Aim #2.  Conducting a factor analysis with the present sample became important 
because the samples used by existing studies that conducted previous factor analysis on 
the causal items of the IPQ-R were somewhat different from the present sample.  The 
first factor analysis was by the developer of the scale (Moss-Morris et al., 2002) using a 
sample of adults with various medical illnesses but did not explicitly indicate the racial 
demographics of the sample; in addition, the sample was recruited from Europe.  Another 
study by Pickett et al. (2014) conducted principal component factor analysis using a 
sample of Black hypertensive adults 18 to 65 years with lower educational level than the 





and community clinics.  Recruitment for the present study was more structured, with 
diagnosis of essential or primary hypertension was verified through chart review; 
additionally, over half of the sample had a four-year college degree or higher.  These two 
previous studies did not provide explicit explanation or steps on how factor selection 
decisions were made.  
  In the present study, the decision to assign an item to a factor was based on a 
priori criteria of factor loadings greater than or equal to .40 and for items cross-loading 
high into two factors; if the difference between the loadings was  less than or equal to .20, 
the item was retained and assigned to the factor with the higher or highest loading; but if 
the difference was  less than .20, the item was not assigned to any factor (Ferguson & 
Cox, 1993).  An acceptable loading for each factor was at least three items (Watson & 
Thompson, 2006).   
To address the second but primary aim of the study, a multiple regression was 
conducted to test the relationships between medication adherence and perceptions about 
hypertension timeline, controllability, consequences, emotional representation, illness 
coherence, and cause among Black hypertensive adults 35 to 65 while controlling for the 
covariates (age, educational level, and experience of hypertension-related symptoms) that 
demonstrated acceptable correlation with the dependent variable (medication adherence).   
Preliminary univariable analyses were conducted to ensure that assumptions of 
multiple regression were not violated (linearity, normal distribution, and uncorrelated 
errors).  Initial descriptive analyses conducted on the dependent variable (medication 
adherence) revealed evidence of high kurtosis (3.202; SE = .442) or skewed distribution 





more normal score distribution with a Kurtosis score of .213 (SE = .442).  Next a 
univariable analysis was conducted using Pearson correlation coefficients to examine the 
relationship between the dependent variable (medication adherence) and the nine 
subscales of the IPQ-R (Timeline, Cyclical Timeline, Consequences, Illness Coherence, 
Emotional Representation, Lifestyle and Uncontrollable Causal Views, Psycho-
Biological Causal Views, Personal Control, Treatment Control).  
Only two subscales of the IPQ-R had statistically significant positive correlation 
with medication adherence: Cyclical Timeline  (r = .246, p = .007) and Emotional 
Representation (r = .179, p = .05); however, at the recommendation of the statistician, 
variables with a non-significant statistical correlation (greater than .05 but less than .1) 
with medication adherence were retained to be included in the model in order to prevent 
premature elimination of predictor variables that could potentially make a significant 
contribution to the variance in the multiple regression model.  For this reason, the 
Consequences subscale, which had a negative relationship with medication adherence (r 
= -159, p = .085), was retained for inclusion in the model.  In total, only three out of the 
nine IPQ-R subscales were included in the multiple regression model. 
 Univariable analyses were conducted to evaluate the correlation between each of 
the covariates (depression, educational level, age, duration of hypertension diagnosis, 
experience hypertension-related symptoms, and severity of hypertension) and the 
dependent variable (medication adherence).  Using Pearson correlation coefficients, age 
was found to have a significant negative correlation with medication adherence (r = -260, 
p = .004).  The older one is, the lesser their score on medication adherence—meaning the 





connotes better adherence to medication.  Using independent sample t-tests, there was a 
statistically significant association between experience of worrisome hypertension-related 
symptoms and medication adherence scores (t (116) = 3.06, p = .003). Those 
experiencing worrisome hypertension symptoms had higher mean scores on medication 
adherence (M = 2.6, SD =. 26) than those not experiencing worrisome hypertension-
related symptoms (M = 2.4, SD =.24).  This result indicates that those who experienced 
worrisome hypertension symptoms had worse medication adherence than those that did 
not experience worrisome hypertension symptoms.  Furthermore, using an independent 
sample t-test, history of depression did not affect medication adherence scores (p = .089).  
Using the one-way ANOVA, educational level was found to have a statistically 
significant relationship with medication adherence (p = .007).  The less education one 
has, the higher their scores on medication adherence, meaning they are less adherent.  No 
statistically significant relationships were found between number of hypertension 
medications, duration of hypertension and severity of hypertension and medication 
adherence; thus these covariates were not included in the initial multiple regression 
model. 
Finally, individual ANCOVA analyses were conducted to explore gender 
differences in medication adherence and illness perception scores among the nine IPQ-R 
subscales.  Potential effects of certain covariates were controlled for during ANCOVA 
for the IPQ-R subscales that demonstrated significant correlations with any or all the 
covariates at p < .05 for the IPQ-R subscales that had no significant correlation with any 
of the covariates.  ANCOVA was conducted without controlling for any covariates since 





Univariable analyses was conducted to evaluate the correlation between the 
respective dependent variables (the nine IPQ-R subscales) and each of the covariates to 
be controlled for in ANCOVA (age, educational level, and duration of hypertension) 
since ANCOVA requires that each of the covariates should be significantly correlated 
with the dependent variable (Pallant, 2007).  Homogeneity of regression slopes, which 
requires that the relationship between the covariate and the dependent variable for the 
grouping variable (gender) is the same (an assumption of ANCOVA), was tested (Pallant, 
2007).  For the IPQ-R subscales that had no significant correlation with any of the 
covariates, ANCOVA was conducted without controlling for any covariates to explore 
gender differences in scores. 
Results 
Sample characteristics.  The PI approached a total of 200 participants from four 
primary care clinics over a ten-week period for recruitment into the study.  Ten 
participants who met inclusion criteria declined participation due to outright non-interest, 
being in a hurry, or complaint that study questionnaire was too long.  Seventy participants 
did not meet inclusion criteria due to age lower than 35 or greater than 65 years, history 
of hypertension less than one year, or having no history of hypertension.  A total of 120 
participants signed consent and completed study questionnaires, however, upon chart 
review, two participants were excluded due to history of sleep apnea or renal artery 
disease.  Finally, data from a total of 118 participants were included in the analyses.   
Table 1 depicts the descriptive statistics for the continuous variables, while Table 
2 depicts the sample’s categorical demographic characteristics. The total sample size was 





up 52.5% (n = 62) of the sample.  Participants were generally educated; with 51% having 
a four-year degree or higher; with only 1.7% (n = 2) having less than a high school 
education. 
Duration of hypertension ranged from 1 to 40 years (M = 10.09; SD = 7.43).  
Overall, 42% (n = 50) had normal systolic blood pressure (SBP < 140; 34.7% [n = 41]), 
had mild or stage 1 hypertension (SBP 140 to ≤ 159), while 22.9% (n = 27) had severe 
(stage 2) systolic hypertension (SBP ≥  160mm Hg), with 8.5% (n = 10) having severe 
diastolic hypertension (DBP ≥ 100mmHg).  
 Thirty-seven (31.4%) of the sample experienced worrisome hypertension-related 
symptoms.  Only 16.1% (n = 19) had a history of depression.  Most (91.5%, n = 108) of 
the sample indicated they have health insurance that pays for their medications and 
doctors’ visits.  The sample was mostly (69.5%, n = 82) employed with only 13.6 % (n = 
16) indicating they were retired. 
 Descriptive statistics for the IPQ-R subscales are included in Table 1.  Items for 
both the illness representation (IR) and the causal subscales of the IPQ-R were scored on 
a 5-point Likert scale with scores ranging from 1 (strongly disagree) to 5 (strongly agree) 
and summed to obtain subscale scores.  The varying number of items in each subscale 
was considered in evaluating and comparing the strength of respondents’ perceptions 
across the subscales by dividing each of the subscale scores by the number of items, 
resulting in the average item response for the subscale on a scale of 1 to 5.  The sample 
agreed that that hypertension can be controlled through personal endeavor (Personal 
Control: M = 4.1) and by prescribed medical treatment (Treatment Control: M = 4.0).  





of their hypertension (Illness Coherence: M = 3.8), that  hypertension is caused by a 
combination of psychological and biomedical risk factors (Psycho-Biomedical Causal 
Views: M = 3.3), that  hypertension is a burden on their lives (Consequences: M =  3.0), 
and is a chronic condition (Timeline,: M = 3.1). The sample, however, disagreed that 
hypertension is unpredictable (Cyclical Timeline: M = 2.8), that factors related to 
unhealthy lifestyle choices and uncontrollable factors (Lifestyle and Uncontrollable 
Causal Views: M = 2.2), or that hypertension instigates emotional reactions (Emotional 






Table 1    
Continuous Variables: Descriptive 
 n Minimum Maximum Mean 
Standard 
Deviation 
Age 118 37 65 53.85 7.881 
HTN Duration (Years) 118 1 40 10.09 7.433 
Timeline 118 6 30 18.28 5.6 
Cyclical Timeline  118 4 20 11.4 3.9 
Consequences 118 9 26 16.97 3.9 
Personal Control 118 14 30 24.8 3.5 
Treatment Control 118 12 25 20 3.1 
Illness Coherence 118 8 25 19.2 3.9 
Emotional Representation 118 6 30 15.6 4.87 
Lifestyle and Uncontrollable 
Causal Views 
118 7 27 15.2 5.09 
Psycho-Biomedical Causal 
Views 
118 7 35 23.02 5.34 







Table 2  
Categorical Demographic Variables 
                Variable Frequency Percent 
Gender Male 62 52.5 
Female 56 47.5 
Education Less than high school 2 1.7 
High school 20 16.9 
Some college or trade 
school 
36 30.5 
Four-year college or 
higher 
60 50.8 
Average Systolic  
Blood Pressure 
 140 – 159 (mild) 41 34.7 
160 or greater (severe) 27 22.9 
Less than140 (normal) 50 42.4 
Average Diastolic  
Blood Pressure 
90 - 99 (Mild) 23 19.5 
100 or greater (severe) 10 8.5 
Less than 90 (normal) 85 72 
Experience Worrisome 
HTN Symptoms 
Yes 37 31.4 
No 81 68.6 
Depression History Yes 19 16.1 
No 99 83.9 
Health Insurance Yes 108 91.5 
No 10 8.5 
Employment Status Employed 82 69.5 
Unemployed 20 16.9 






Hypertension causal attributions.  The first objective of this study was to 
explore the sample’s perceptions about cause of hypertension.  The hypothesis was that 
perception of psychological factors as cause of hypertension will explain the highest 
variance in causal attributes of hypertension among other factors. 
To examine this aim and hypothesis, the 18 causal items of the revised Illness 
Perception Questionnaire (IPQ-R) were subjected to a principal component factor 
analysis (PCA) in SPSS.  Prior to conducting the analysis, the adequacy of the data for 
factor analysis was evaluated. The Kaiser-Meyer-Oklin value was .73, which exceeds the 
recommended value of .6 (Kaiser, 1970, 1974 as cited by Pallant, 2007), while Bartlett’s 
Test of Sphericity was statistically significant (p = .000).  
 The initial PCA without rotation identified five causal factors with eigenvalues 
greater than one. These factors were further examined with PCA with varimax rotation, 
which extracted five components with eigenvalues greater than one, explaining 17.8%, 
17.5%, 9.9%, 7.8% and 7.9% of the variance respectively, with an approximate 
cumulative total of 63% of the variance explained.   However, the scree plot suggested a 
somewhat weak break after the third component.  Upon evaluation of the rotated 
component matrix of the five-factor solution, while also examining factor loadings, cross-
loadings, and number of items loading on each factor, only three factors met the study’s a 
priori criteria for factor retention; however, this three-factor solution had a large number 
of items with high cross-loadings on different factors.  To further evaluate these three 
factors, another PCA with varimax rotation was conducted specifying a fixed three-factor 
solution. The three-factor solution had eigenvalues exceeding one, explaining 18.9%, 





of variance explained.  However, the rotated component matrix revealed many cross-
loadings that did not meet the set a priori criteria for item inclusion into a factor, 
especially on factor 3, which left factor 3 with less than three items loading high in it.  
The number of items loading in each factor, in addition to the scree plot that showed a 
sharp break after the second component suggested that a two-factor solution could be a 
better representation of the causal attributions of the IPQ-R.  A final PCA with varimax 
rotation specifying a fixed two-factor solution resulted in eigenvalues greater than one. 
The two factors explained 22.7% and 18.1% of the variance in causal attribution 
respectively, with a cumulative 40.8% variance explained. Each of these two factors were 
comprised of seven items with high loadings and only minimal cross-loadings. The 
rotated component matrix (Table 3) revealed that two items (“my mental attitude” and 
“my emotional state”) cross-loaded high into the two factors and did not meet the criteria 
to be assigned to any factor; additionally, two items (“ageing” and “chance or bad luck”) 
did not load high in any factor; thus these four items were not included in the factor 
assignment.  
An oblique rotation with Promax also revealed the same result as the varimax 
rotation outlined above.  The items loading in these two factors provide the most 
conceptually coherent explanation or representation of the causal views. This result 
shows that sample’s views about cause of hypertension clustered around two factors, 
namely: 
Factor 1. This factor, Lifestyle and Uncontrollable Causal Views, included 
smoking, alcohol, accident, personality, altered immunity, pollution in the environment, 





lifestyle choices, such as smoking and alcohol use, in addition to factors outside an 
individual’s control, such as personality, pollution in the environment, accident, altered 
immunity, or germs.  Examination of the items loading into this factor seemed to 
represent factors that are either not associated with hypertension or are not always 
identified as standard risk factors.  Excessive alcohol intake and smoking, though 
recognized as risk factors for hypertension by the biomedical community (AHA, 2017d), 
may not be viewed by lay individuals as risk factors for hypertension.  
Factor 2.  This factor was labeled Psycho-Biomedical Causal Views.  Items that 
loaded into this factor are factors related to life stressors or psychological issues such as 
stress, overwork, behavior, family problems, and known risk factors for hypertension, 
such as family history, poor medical care, and diet or eating habits.  Known predisposing 
risk factors for hypertension and stress-inducing items clustered together in this factor.  
Dietary habits, especially a high-sodium diet, are a very important known risk factor for 
hypertension (AHA, 2017d). The bulk of the self-care education that healthcare providers 
often give to hypertensive patients, especially Blacks, relating to diet lies on reducing 
sodium intake; higher intake of sodium is associated with an increase in blood pressure 
among Blacks (Wright et al., 2003).  This common advice may explain why this item 
loaded into the second factor with the rest of the known risk factors for hypertension in 





































      1           2 
Accident or injury .812* -.029 
My personality .757* .089 
Altered immunity .735* -.102 
Smoking .666* .102 
Alcohol .596* .162 
My emotional state .582# .396# 
Pollution in the environment .451* .212 
Germ or virus .420* -.066 
Ageing .387@ .125 
Chance or bad luck .240@ .096 
Stress or worry -.034 .674* 
Overwork .331 .648* 
My own behavior -.003 .626* 
Family problems or worries .367 .606* 
Diet or eating habits .054 .604* 
My mental attitude .544# .586# 
Poor medical care in my past .181 .566* 
Hereditary—it runs in the family -.063 .560* 
Note. 
*: items loaded strongly in factor 1 or 2 
#: Items cross-loading in factor 1 and 2 not meeting cross-loading criteria 
for factor assignment 





Relationship between medication adherence and hypertension perceptions. 
The primary objective of this study was to examine whether there is any relationship 
between medication adherence and perceptions about hypertension timeline, 
controllability, consequences, emotional representation, illness coherence, and causal 
attributions among Black hypertensive adults 35 to 65 while controlling for depression, 
educational level, age, duration of hypertension diagnosis, experience of hypertension-
related symptoms, and severity of hypertension. The hypothesis was that there will be a 
statistically significant relationship between medication adherence and hypertension 
perceptions, where high scores on the subscales of the IPQ-R will be associated with 
higher scores on medication adherence.  
 Three of the IPQ-R subscales were significantly (p < .10) positively correlated 
with medication adherence, including Cyclical Timeline (r = .246, p = .007), Emotional 
Representation ( r = .179, p = .05), and  Consequences  (r = -159, p = .085); these were 















Correlation between IPQ-R subscales and medication adherence 
Independent Variables Medication Adherence 
 (Dependent Variable) 
Timeline r = -.071; p =.446 
Cyclical Timeline r =.246; p = .007* 
Consequences r = -.159; p = .085* 
Personal Control r =-.130; p = .161 
Treatment Control r = -.058; p =.536 
Illness Coherence r = -.058; p = .534 
Emotional Representation r = .179; p = .053* 
Lifestyle and Uncontrollable Causal 
Views 
r = .081; p =.381 
Psycho-Biomedical Causal Views r = .092; p = .321 







Hierarchical multiple regression was conducted to examine the ability of the three 
IPQ-R subscales (Cyclical Timeline, Emotional Representation, and Consequences) to 
predict levels of medication adherence while controlling for age, educational level, and 
experience of worrisome hypertension-related symptoms. The covariates (educational 
level, age, and experience of worrisome hypertension symptoms) were entered in step 1 
(model 1), which explained 18.1% of variance in medication adherence.  After entering 
the three predictor variables (Cyclical Timeline, Consequences, and Emotional 
Representation) in model 2, the model (Table 5) together explained a total of 23.9% 
variance in medication adherence, F (6, 111) = 5.821, p < .001. The three predictor 
variables (Cyclical Timeline, Consequences, and Emotional Representation), explained 
an additional 5.8% of variance in medication adherence after controlling for age, 
educational level, and experience of worrisome hypertension symptoms, R2 change = 
.058, F change (3, 111) = 2.84, p = .041.  In the final model, only age (beta = -.190, p = 
.033), educational level (beta = -.232, p = .007), and Consequences (beta = -.203, p = 
.022) made significant statistical contribution to the variance in medication adherence 
(Table 5).  Of the three IPQ-R subscales entered in the model, only Consequences 
demonstrated a significant statistical relationship with medication adherence. The result 
indicates that the stronger the sample believes that hypertension has consequences, the 











Multiple regression: Model summary and coefficients 
 








Change F Change df1 df2 
Sig. F 
Change 
2 .489b .239 .198 .22615 .058 2.838 3 111 .041** 
 





t Sig. B 
Std. 
Error β 
    2 
 
 
(Constant) 3.158 .225  14.008 .000 
Age -.006 .003 -.190 -2.158 .033* 
Educational Level -.072 .026 -.232 -2.724 .007* 
Experience Worrisome  
HTN Symptoms 
-.069 .049 -.128 -1.402 .164 
Cyclical Timeline .010 .006 .149 1.657 .100 
Consequences -.013 .006 -.203 -2.327 .022* 
Emotional representation .006 .005 .120 1.308 .194 
Note.  ** Level of model 2’s statistical significance(p<.05) when the three IPQ-R subscales were 
added into the model.  
*Variables that individually significantly predicted medication adherence. 






Gender difference in hypertension perceptions and medication adherence. 
Individual ANCOVA was conducted to test for gender differences using each of the nine 
IPQ-R subscales as dependent variables while controlling for covariates when applicable.  
Age had a significant statistical correlation with Timeline, Cyclical Timeline, Treatment 
Control, Personal Control, and Psycho-Biomedical Views (Table 6) and thus was 
controlled for in their respective analyses.  Duration of hypertension had a significant 
statistical relationship with Timeline, Illness Coherence, and Personal Control (Table 6) 
and was controlled for during the analyses.  Educational level had a statistically 
significant correlation with Treatment Control (Table 6) and thus was controlled for in 








Correlation between IPQ-R subscales and covariates for ANCOVA 
Variable Age Duration of 
Hypertension 
Education Level 
Timeline r =.200, p =.030* r = .218; p =.018* F =.400;  p =.753 
Cyclical Timeline r = -218;  p =.018* r =-.049;  p =.598 F =.932;  p =.428 
Consequences r =.002;  p =.980 r =.093;  p =.316 F =.980;  p =.405 
Personal Control r =-222;  p =.016* r =-.179;  p =.052* F =1.656;  p =.181 
Treatment Control r =-190;  p =.040* r =-.147;  p =.111 F =2.732;  p =.047* 
Illness Coherence r =-167;  p =.070 r =-.185;  p =.045* F =.287;  p =.834 
Emotional 
Representation 




r =.056;  p =.547 r =.083;  p =.371 F =.244;  p =.865 
Psycho-Biomedical 
Views 
r =-234;  p =.011* r =-.085;  p =.359 F =.983;  p = .403 








The final objective of this study was to explore to what extent hypertension 
perceptions (Aim 3a) and medication adherence (Aim 3b) differ by gender, while 
controlling for certain confounding variables.  Aim 3a sought to explore gender 
differences on the scores of the IPQ-R subscales while controlling for educational level, 
age, and duration of hypertension diagnosis. 
Homogeneity of regression slopes, an assumption of ANCOVA that requires that 
the relationship or interaction between the covariate and the dependent variable for each 
group (gender) to be the same, was conducted (Pallant, 2007) (Table 7).  This test was 
only conducted between the IPQ-R subscales and the covariates they demonstrated 
significant statistical correlation with; those IPQ-R subscales without any significant 


















 Homogeneity of regression slopes: Interaction 
Variable Gender * Age Gender * 
Hypertenion 
Duration 
Gender * Education  
Timeline F =.103; p =.749 F = .605; p =.438 N/A 
Cyclical Timeline  F = .017; p =.898 N/A N/A 
Personal Control F = .953; p =.331 F = .078; p =.780 N/A 
Treatment 
Control 




F = .158; p = .692 N/A N/A 
Illness Coherence N/A F =.578; p =.449 N/A 
Consequences N/A N/A N/A 
Emotional 
Representation 











As Table 8 depicts, individual ANCOVA analyses showed no statistical 
significant gender differences in Timeline (p = .532) and Personal Control (p =. 625) 
scores while controlling for age and duration of hypertension, or in Cyclical Timeline (p 
= .517) and Psycho-Biomedical Causal Views (p = .145) scores while controlling for age.  
Furthermore, no statistically significant gender differences in Treatment Control scores 
while controlling for age and educational level (p = .734); and no significant statistical 
gender difference in Illness Coherence scores while controlling for duration of 
hypertension (p = .578). 
Additionally, individual ANCOVA was conducted for Consequences, Emotional 
Representation, and Lifestyle and Uncontrollable Causal Views without controlling for 
any covariates since these three IPQ-R subscales demonstrated no significant statistical 
correlations with any of the covariates of interest (age, hypertension duration, and 
educational level).  There were no statistically significant gender differences in 
Consequences or Emotional Representation scores, but there was a statistically 
significant gender difference in Lifestyle and Uncontrollable Causal Views scores (Table 
8).  Compared to females (M = 14.196), males had a significantly higher adjusted mean 
score (M = 16.183, p = .034) on the perception or belief that hypertension is caused by 
factors related to a combination of poor lifestyle choices, such as smoking and alcohol 










Adjusted mean scores and standard error: Gender differences in hypertension 


















a .751 16.449 19.425 
Cyclical 
Timeline 
Male 11.215a .495 10.235 12.196 
p = .517 Age 
Female 11.690a .522 10.657 12.723 
Personal Control Male 24.946a .437 24.080 25.813 




a .461 23.718 25.544 
Treatment 
Control 
Male 20.095a .395 19.313 20.877 
p = . 734 
Age & 




Male 23.705a .669 22.380 25.030 
p = . 145 Age 
Female 22.256a .705 20.859 23.652 
Illness 
Coherence 
Male 19.031a .489 18.063 20.000 
p =.578 
HTN 
Duration Female 19.429a .515 18.410 20.449 
Consequences Male 16.813 .502 15.818 17.807 
p =.645 None 
Female 17.150 .528 16.104 18.196 
Emotional 
Representation 
Male 15.484 .622 14.252 16.715 
p =.799 None 




Male 16.183 .637 14.921 17.445 
p =. 034* None 
Female 14.196 .670 12.869 15.524 





For Aim 3b, ANCOVA was conducted to evaluate whether there was any gender 
difference in medication adherence scores while controlling for age, number of 
medications, educational level, and comorbidity (depression).  Age was not included as a 
covariate in this analysis as the interaction between age and gender was significant (p = 
.007), which violates the assumption of homogeneity of regression slopes (Leech, Barrett, 
& Morgan, 2015; Pallant, 2007).  Additionally, “number of hypertension medications” 
taken was not included because the univariable analysis showed it had no significant 
statistical correlation with the outcome variable (medication adherence).  The result 
showed that there was no statistically significant difference between genders in 



















 Gender differences in medication adherence: Test of between-subjects effects 
Source 
Type III Sum 
of Squares df 
Mean 





.673a 3 .224 3.766 .013 .090 
Intercept 25.444 1 25.444 427.154 .000 .789 
Education .488 1 .488 8.187 .005 .067 
Depression 
History 
.092 1 .092 1.546 .216 .013 
Gender .012 1 .012 .197 .658* .002 
Error 6.791 114 .060    




    















The present study first sought to investigate the factor structure of hypertension 
causal attribution among Black hypertensive adults aged 35 to 65 years.  The second but 
primary objective was to examine whether there is an association between hypertension 
perceptions and medication adherence among Black hypertensive adults after controlling 
for the effects of certain confounders, and the final objective was to explore gender 
differences in hypertension perceptions and medication adherence.  
Hypertension causal attributions.  First, the factor structure of causal 
attributions of hypertension was tested.  Two factors of hypertension causal attribution 
were identified.  The first factor was labeled “Lifestyle and Uncontrollable Causal 
Views,” while the second factor was labeled “Psycho-Biomedical Causal Views.”  These 
two causal attribution subscales demonstrated acceptable internal consistency reliability. 
The hypothesis was that psychological attribution of cause of hypertension would 
explain the highest variance in causal attributions, however, the Lifestyle and 
Uncontrollable Causal View as the cause of hypertension explained more variance 
(22.7%) in causal attribution of hypertension than the Psycho-Biomedical View, which 
explained 18% of variance.  The results showed that items related to psychological 
factors as a cause of hypertension clustered together with known hypertension 
predisposing risk factors.  Based on the a priori factor selection criteria used in this study, 
the IPQ-R causal attributional component can be considered as two conceptually 
meaningful subscales for middle-aged Black adults with hypertension who have access to 





Though Lifestyle and Uncontrollable Causal Views explained the highest 
variance in causal hypertension attribution among this sample, on a 1 (strongly disagree) 
to 5 (strongly agree) scale, the mean subscale score for the Psycho-Biomedical Causal 
View was higher than the mean score for Lifestyle and Uncontrollable Causal View 
subscale.  The sample neither agreed nor disagreed that a combination of 
psychological/life stressors and known hypertension risk factors caused their 
hypertension; however, the sample disagreed that hypertension is caused by a 
combination of unhealthy lifestyle choices and factors outside their control. 
In contrast with the present study, Pickett et al. (2014) used a sample of 111 Black 
hypertensive adults and extracted five factors and reported that psychological or life 
stressor related items loaded together into the same factor and explained the most 
variance.  This was followed by views that hypertension is caused by factors outside an 
individual’s control, such as germs, altered immunity, chance, or accident; however, 
known or standard risks factors for hypertension such as aging, poor medical care, and 
family history seemed to have loaded into different factors without a clear or coherent 
conceptual definition.  Additionally, the developer (Moss-Morris et al., 2002) of the IPQ-
R extracted four causal attribution subscales where the psychological items clustered 
together and explained the most variance, followed by known risk factors for 
hypertension and items related to poor immunity clustered in respective factors. 
The present study’s causal attribution contrasts from other studies in that both 
standard hypertension risk factors and psychological/life stressors loaded together in the 
same factor.  Previous studies, both qualitative and quantitative, have mostly reported 





around stress/psychological models versus biomedical models (Heckler et al., 2008; 
Lukoschek, 2003; Wilson et al., 2002;  Heurtin-Roberts & Resisin, 1990); however, a 
new finding from the present study is that there may be a shift with this population, or 
subgroups within it, which is beginning to view the cause of hypertension within a model 
that encompasses both the psychological/stress and biomedical models together.   
The contrast in the present study’s causal attribution result could be due to the sample’s 
higher educational level, age, and the use of a more structured recruitment strategy 
compared with previous studies.   
Although two causal attribution factors were identified in this study with the 
Lifestyle and Uncontrollable Causal Views factor explaining the most variance, a look at 
the individual subscale mean score on these two factors clearly indicates that the sample 
does not believe that hypertension is caused by factors related to unhealthy lifestyle such 
as smoking and alcohol in combination with factors outside their control.  The sample, 
however, neither agreed nor disagreed that a combination of life stressors and known risk 
factors for hypertension caused their hypertension.  This finding suggests that the sample 
has some level of ambivalence regarding the cause of hypertension.  Several old 
qualitative studies have reported misconceptions about hypertension among Black 
hypertensive adults that are related to believing that psychological factors rather than 
biomedical factors cause hypertension (Boutin-Foster, Ogedegbe, Ravenell, Robins, & 
Charlson, 2007; Ogedegbe et al., 2004; Schlomann, & Schmitke, 2007; Wilson et al., 
2002); however, in the present study these two factors clustered together.  
Relationship between medication adherence and hypertension perceptions.  





relationship between medication adherence and perceptions about hypertension timeline, 
controllability, consequences, emotional representation, illness coherence, and cause 
among Black hypertensive adults 35 to 65 while controlling for depression, educational 
level, age, duration of hypertension diagnosis, experience of hypertension-related 
symptoms, and severity of hypertension.  The hypothesis that there would be a 
statistically significant relationship between medication adherence and hypertension 
perception, where high scores on the subscales of the IPQ-R would be associated with 
better medication adherence scores, was partially supported. 
Only three of the nine perception subscales IPQ-R (Cyclical Timeline, 
Consequences, and Emotional Representation) demonstrated a statistical correlation with 
the outcome variable (medication adherence) and were included in the multiple 
regression model; only one subscale, Consequences, had a statistically significant 
association with medication adherence. Consequences appears to be a strong predictor of 
medication adherence; though additional variance explained by the addition of the three 
IPQ-R subscales into the model was small (5.8%), it was significant (p = .041).  The 
stronger the sample’s belief that hypertension is a disease that increases burden on one’s 
life, the better their medication adherence.  It is very possible that stronger belief that 
hypertension has consequences predicted medication adherence in this sample due to 
existing knowledge or personal experiences of the burden of hypertension on their lives 
or those of their friends or family members.  The other two subscales (Emotional 
Representation and Cyclical Timeline) may not have been significant predictors of 
medication adherence among this sample because the sample may have had hypertension 





any emotional reactions that prompt engaging in coping behavior, such as medication 
adherence.  This is consistent with the result of the subscale mean scores discussed 
earlier, which revealed that this sample does not believe that hypertension is a disease 
that is unpredictable or induces any emotional reaction. This also suggests that this 
sample may have a good understanding of their hypertension.  As noted earlier, the 
sample have a strong belief that their high blood pressure can be controlled by their self-
efficacy (personal control) and treatment control; thus they do not experience any 
emotional upset regarding their disease.  
This result provides partial support for the hypothesis that hypertension 
perception will be associated with medication adherence.  The finding of this study has 
lent credence to findings from previous studies where views about hypertension, 
especially cause, were found to guide self-management behavior among Black 
hypertensive adults (Heckler et al., 2008; Heurtin-Roberts & Reisin, 1990).  Additionally, 
the study by Pickett et al. (2014) examined the association of illness perceptions and 
medication adherence among Black adults found that illness coherence was a predictor of 
self-care behaviors (F = 7.10, p < .01).  Ross et al. (2004) explored the role of illness 
perceptions and treatment beliefs in medication adherence among hypertension patients 
in the United Kingdom and reported that emotional representation (p = .01) and personal 
control (p = .01) significantly predicted medication adherence.  A study by Chen, Tsai, 
and Lee (2009) among Taiwanese hypertensive adults reported that treatment control, 
risk factors, and psychological attribution predicted medication adherence. 
Additional findings of the current study were that both age and educational level 





justifying the need to use them as covariates in the multiple regression analysis.  The 
older the participant, the better their medication adherence; and the higher their 
educational level, the better their medication adherence.  Heckler et al. (2008) and Ross, 
Walker, and Macleod (2004) also noted an association between medication adherence and 
age.  Nevertheless, with covariates and the three subscales noted above in the model, only 
23.9% of the variance in adherence was explained.  
Because most of what is known about hypertension perceptions and medication 
adherence among Black adults has been based on qualitative studies with samples that 
were majority female, the third and final aim of the present study was to explore whether 
there were any gender differences in illness perceptions and medication adherence.  
The results showed only the Lifestyle and Uncontrollable Causal Views of 
hypertension demonstrated a statistically significant gender difference; compared to 
women, men had a slightly stronger belief in this factor as a cause of hypertension. There 
were no statistically significant gender differences on the scores of the other eight IPQ-R 
subscales or on the adherence scale, indicating that males and females were similar in 
their perceptions of hypertension and their reports of antihypertensive medication 
adherence.  Ross et al. (2004) found that men were more likely than females to believe 
that risk factors caused hypertension.   
In summary, the results indicate that out of the nine subscales of the IPQ-R, most 
had no statistically significant association with medication adherence, and for the three 
that demonstrated significant correlations with medication adherence (Consequences, 
Emotional Representation, and Cyclical Timeline), only perceptions about consequences 





hypertension causes a negative burden on life predicted better medication adherence.  
Additionally, men are more likely to believe that lifestyle choices and uncontrollable 
factors cause hypertension than women.  Even though most studies about hypertension 
perceptions and medication adherence among Black adults have been based on studies 
with majority-female samples, the result of the present study suggests that Black males 
likely hold about the same views as Black females. 
Strengths.  The major strength of the present study is that sample was 
homogenous with respect to access to primary care in that all participants were 
established patients in one of four primary care settings.  An important strength of the 
PCA conducted in the current study is that explicit a priori criteria were used in deciding 
how items were selected, unlike the two previous studies that conducted PCA on the 18 
causal items of the IPQ-R (Pickett et al., 2014; Moss-Morris et al., 2002).  These two 
previous studies did not give a clear report on how factors were selected or how cross-
loadings were handled.  Additionally, the two factors extracted in the current study 
demonstrated acceptable evidence of internal consistency reliability.  The sample, though 
more educated than the usually lower-educated samples often seen in studies of Black 
adults, were recruited from multiple clinics that serve a lower-to-middle-class Black adult 
patient population, thus increasing the chance that the target population was recruited.  In 
contrast with the present study’s sample, the sample in Pickett et al. (2014) recruited 
participants with lower educational levels from shopping malls, community housing, and 
clinics, while the sample in Moss-Morris et al. (2002) included individuals with various 





inpatient and outpatient settings in Europe.  Using a chart review to confirm diagnosis of 
primary/essential hypertension was also a strength. 
 Additionally, this is one of the few studies that measured hypertension 
perceptions and medication adherence quantitatively and used standardized 
questionnaires.  To the author’s knowledge, the current study is the second study within 
the last 10 years that has examined the impact of perceptions of hypertension on 
antihypertensive use. The present study, however, is the first to report an association 
between consequences and medication adherence among Black hypertensive adults.  
Furthermore, the present study has partially presented evidence that Black hypertensive 
males and females may hold the same perceptions regarding hypertension.  
Limitations.  The present study is not without limitations.  Misclassification of 
medication adherence or illness perceptions is likely a limitation of this study due to the 
use of self-report questionnaires to measure hypertension perceptions and medication 
adherence.  Self-report questionnaires may lead to participants’ overestimation of 
adherence, recall bias, and likelihood for giving socially acceptable responses (Morisky 
et al., 2008).  Because of the use of a cross-sectional design in this study, cause and effect 
cannot be ascertained.  Another important limitation is the inability to address the impact 
of acculturation on hypertension perceptions and/or medication adherence, especially for 
foreign-born Blacks.  However, the current study’s focus was not strictly on a foreign-
born sample of Black hypertensive population.  Finally, not measuring depression with a 
standardized instrument was also a limitation of this study.  
Implication.  The findings of this study are generalizable to Black hypertensive 





primary care settings.  The findings of this study, especially as it relates to perceptions 
about cause of hypertension, revealed that Black adults hold ambivalent views about 
what factors cause hypertension, however, this sample seem to lean toward a belief that 
hypertension is caused by a combination of psychological/life stressors and known risks 
factors for hypertension.  Furthermore, in this study, perceptions that hypertension is a 
disease with consequences or burden was found to be significantly associated with 
medication adherence.  
These findings highlight the need for clinicians and nurse educators to frequently 
assess patients’ perceptions about their hypertension, educating and correcting any 
misconceptions the patient may have.  Since knowing that strongly believing that 
hypertension has complications is associated with better medication adherence, nurses 
that take care of Black adults with hypertension should frequently highlight the 
importance of medication adherence as a means to reduce complications and the general 
health burden of uncontrolled hypertension, especially at the time of diagnosis and at 
every encounter in the healthcare setting.  Exploring patients’ perceptions of hypertension 
presents clinicians with an important opportunity to correct misconceptions about the 
disease.  Assessing patients’ perceptions about their hypertension creates an opportunity 
for the clinicians to identify patients that may have poor outcome from hypertension 
earlier on so that interventions can be initiated.   
 Despite the limitations discussed above, there is value in the knowledge gained, 
and the results will inform the design of a longitudinal study with a larger sample size 
that could further examine and clarify hypertension beliefs and its role in medication 





this area could focus on exploring the role of acculturation on hypertension perceptions 
and medication adherence among foreign-born hypertensive Black adults residing in the 
United States. Future studies should also explore how perceptions of hypertension differ 
by blood pressure control status. 
Conclusion 
This study has demonstrated that illness perceptions, especially perception that 
hypertension places a burden on one’s life, is related to medication adherence among 
Black hypertensive adults aged 35 to 65 years.  This study’s results further established 
that there is ambivalence among Black hypertensive adults regarding whether the 
combination of life stressors and known hypertension risk factors are causes of 
hypertension; however, it is also clear in this study that the sample did not agree that 
hypertension is caused by factors not generally accepted as risk factors by the medical 
community.   Although men and women are very similar in reports of their medication 
adherence and their perceptions of hypertension, men are more likely than women to 
attribute cause of hypertension to unhealthy lifestyle choices and influences outside an 
individual’s control.  
 A well-thought out and designed intervention is needed to improve perceptions 
about hypertension and better disease control among Black hypertensive adults; however, 
more studies, such as a repeat of the present one with larger sample sizes, are needed to 
elicit more knowledge and understanding of hypertension perceptions, including 
consequences, and their impact on medication adherence or general self-care 





There is a need for future research to focus on populations with the highest 
prevalence of uncontrolled hypertension and its complications (Levine et al., 2011).  
Targeting Black hypertensive adults between the ages of 35 to 65 years for interventions 
to improve understanding of hypertension and promote medication adherence will help in 
forestalling potential future negative outcomes that could emanate from uncontrolled 
hypertension among Black hypertensive adults.  Although no specific intervention has 
been ascertained to be a lasting solution to the problem of poor blood pressure control 
among the Black adult population, it is likely that interventions that are designed to 
address all or most of the factors implicated in the poor blood pressure control in the 
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perceptions about hypertension and medication adherence among Black hypertensive 
adults 35 to 65 years, in primary care. Some studies have shown that Blacks or African 
Americans have worse blood pressure control and suffer more severe complications from 
hypertension than other races. The student is conducting a study to examine whether your 
views or understanding about hypertension have any effect on the way you take your 








 If you agree and are able to take part in this study you will first sign the consent 
form. After obtaining your consent, you will be asked to complete two questionnaires and 
a demographic data form.  After you complete the questionnaires, the PI will ask you for 
your name and date of birth in order to review your chart/medical record.  The purpose of 
the chart review is only to verify your eligibility for the study and confirm some of the 
responses on the demographic form. It is very important that you know that participating 
in this study will in no way affect your care at this clinic. Your doctor or healthcare 
provider will not have access to or know about your survey responses. The researcher 




The total amount of time you will be asked to be in this study is only the time it 
takes you to complete the questionnaires. This study involves only one-time completion 
of these questionnaires. Completing the questionnaires and demographic data form will 
take a total of approximately 15 to 20 minutes or less. There will be no other visit or 




You may receive no direct benefit from being in the study; however, your taking 
part may help hypertensive patients like you get better in the future. The major general 
benefit of this study is that it will help inform and support the design of useful 
interventions that can help Black adults in controlling their blood pressure, thereby 
reducing the risks for complications from uncontrolled hypertension.  
 
 
RISKS AND/OR DISCOMFORTS 
One of the possible risks to you as a participant in this study may relate to breach 
of confidential information. However, in this study, confidentiality will be strictly 
maintained to the extent allowable by law. To protect your privacy, the study has created 
study identification numbers that will be written on the survey you completed instead of 
your name; that way no one will know who completed the survey. Your name will not be 
written on any survey you completed.  Information collected is only for research purposes 
and will not negatively impact your treatment or relationship with your healthcare 
providers. Your doctor or any other medical team will also not have access to your survey 
responses. The principal investigator (researcher), her school research advisor, and a 
statistician are the only people that will have access to your data or survey responses.  
Responses from the survey will be analyzed as a group and not on an individual basis. 
Any unneeded information accidentally collected from you will be shredded 
immediately; then the hard copies of the survey responses will be shredded one year from 
the study completion date.  In case the research gets published, no patient identifying 
information will be included in the publication. The researcher will strive to prevent any 
chance of injury or problem to you as you participate in this study and will be willing and 





does not provide medical services or financial assistance for injuries sustained due to 
your participation in this study. 
Another potential risk will be fatigue because of the time you may spend 
completing the questionnaires. You may take a break from this survey as often as you 




You can also choose not to participate in this study as an alternative option to 
participating in this study. 
 
 
STUDY WITHDRAWALYour decision to take part is voluntary. You may decide to 
stop taking part in the study at any time. A decision not to take part or to stop being a part 
of the research project will not change the healthcare services available to you from your 
doctor or other healthcare providers. 
 
 
COSTS, REIMBURSEMENT AND COMPENSATION 
If you decide to take part in this research study, there will be no cost to you as a 
participant in this study; however, you will be given a $10 to $15 gift card to Walmart or 




Please understand that representatives of the University of Texas Health Science 
Center at Houston may review your research and/or medical records for the purposes of 
verifying research data and will see personal identifiers.   However, identifying 
information will not appear on records retained.  You will not be personally identified in 
any reports or publications that may result from this study. There is a separate section in 
this consent form that you will be asked to sign which details the use and disclosure of 




If you have questions at any time about this research study, please feel free to 
contact the principal investigator (STELLA EKE) at 832-683-1540, as she will be glad to 
answer your questions. You can contact the study team to discuss problems, voice 












AUTHORIZATION TO USE AND DISCLOSE 




DATE OF BIRTH:___________________ 
 
Protocol Number and Title:  Association of Illness Perceptions and Antihypertensive 
Medication Adherence Among Black Hypertensive Adults in Primary Care Setting. HSC-
SN-17-0872 
 
Principal Investigator: STELLA EKE 
 By signing this document, you give permission to your doctor to disclose (release) your health 
information that identifies you for the research study named above.   
If you sign this document, you give permission to the researchers to obtain health information from the 
following health care providers: 
Name of Provider Address of Provider Fax Number of 
Provider 
Austin Williams, MD 7015 Almeda Rd suite 5, Houston 
TX 77054 
N/A. PI will be at the 
clinic 
 Albert Oguejiofor, MD 7737 Beechnut suite 200 Houston 
TX 77036 
Same as above 
Arnold Carothers, DO 17121 Westheimer Rd Houston 
TX 77082 
Same as above 
UT-Health Clinic: 
 Delorean Alexander, NP 
Angela Rutherford, NP 
George Delclos,  MD 
 
7000 Fannin suite 1620 Houston 
TX 77030 
Same as above 
The only identifying information will be your name and date of birth on the 
signature page of this form, however, this form will be separated from your completed 
survey. Your completed survey will be assigned a study number instead.  Your consent 





The purpose of the chart review is to verify eligibility for study participation. 
Information to be collected from the medical record include blood pressure readings, 
history of depression, duration of your high blood pressure, diagnosis of primary 
hypertension, and age. 
 The health information listed above may be used by and/or disclosed (released) to 
researchers and their staff.  Your doctor is required by law to protect your health 
information. By signing this document, you authorize your doctor to disclose your health 
information for this research.  
If all information that does or can identify you is removed from your health 
information, the remaining information will no longer be subject to this authorization and 
may be used or disclosed for other purposes. No publication or public presentation about 
the research described above will reveal your identity without another authorization from 
you. 
 Please note that health information used and disclosed may include information 
relating to HIV infection; treatment for or history of drug or alcohol abuse; or mental, 
behavioral health, or psychiatric care.  
  Also note that you do not have to sign this Authorization, but if you do not, you 
may not participate in this research study. Your doctor may not withhold treatment or 
refuse treating you if you do not sign this Authorization.  
  You may change your mind and revoke (take back) this Authorization at any time. 
Even if you revoke this Authorization, researchers may still use or disclose health 
information they already have obtained about you as necessary to maintain the integrity 
or reliability of the current research.  
 
PI Name: STELLA EKE 
The University of Texas Health Science Center at 
Houston 



















Sign below only if you understand the information given to you about this 
research and you choose to take part. Make sure that any questions have been answered 
and that you understand the study. If you have any questions or concerns about your 
rights as a research subject, call the Committee for the Protection of Human Subjects at 
(713) 500-7943. You may also call the Committee if you wish to discuss problems, 
concerns, and questions; obtain information about the research; and offer input about 
current or past participation in a research study. If you decide to take part in this research 
study, a copy of this signed consent form will be given to you. 
 
     
Printed Name of Subject   Signature of Subject   Date               
 
     
Printed Name of Person 
Obtaining Informed 
Consent 
 Signature of Person 
Obtaining Informed 
Consent 
 Date               
 
This study HSC-SN-17-0872 has been reviewed by the Committee for the Protection of 
Human Subjects (CPHS) of the University of Texas Health Science Center at Houston. 
For any questions about research subject's rights, or to report a research-related injury, 























































Black/African-American Hypertensive Adult 
Volunteers Needed for Research Study  
A PhD in nursing student at University of Texas - Houston is 
conducting a dissertation study to investigate the relationship between 
hypertension perceptions and blood pressure medication adherence. This 
study will be conducted by Ms. Stella Eke under the supervision of her 
academic advisor at The University of Texas Health Science Center -
Houston School of Nursing. 
You may be eligible to participate in this study if you are: 
 Black/African-American adult- male or female-35 to 65 years.  
 Have hypertension  
 Ever been prescribed blood pressure medication by your doctor-whether 
you are taking it or not. 
 
Study details/Procedure:  
If you volunteer to participate in this study, you will be asked to complete a 
one-time questionnaire related to the study, which would take 
approximately 15-20 minutes to complete. 
Compensation for your time will be provided. 





The study has been reviewed and approved by the Research Ethics Committee at 
UTHealth 
  
Do you think you may be interested? 
For more information about the study, or to volunteer for this study, 
please contact: 





















































Illness Perception Questionnaire 
We are interested in your own personal views of how you now see your current illness. 
Please indicate how much you agree or disagree with the following statements about your 
illness by ticking the appropriate box. 












IP1 My high blood 
pressure will last a 
short time 
     
IP2 My high blood 
pressure is likely to 
be permanent rather 
than temporary 
     
IP3 My high blood 
pressure will last for 
a long time 
     
IP4 This high blood 
pressure will pass 
quickly 
     
IP5 I expect to have my 
high blood pressure 
for the rest of my 
life 
     
IP6 My high blood 
pressure is a serious 
condition 
     
IP7 My high blood 
pressure has major 
consequences on my 
life 
     
IP8 My high blood 
pressure does not 
have much effect on 
my life 
     
IP9 My high blood 
pressure strongly 
affects the way 
others see me 
     
IP10 My high blood 
pressure has serious 
financial 
consequences 


















IP11 My high blood 
pressure causes 
difficulties for those 
who are close to me 
     
IP12 There is a lot which 
I can do to control 
my symptoms  
     
IP13 What I do can 
determine whether 
my high blood 
pressure gets better 
or worse  
     
IP14 The course of my 
high blood pressure 
depends on me 
     
IP15 Nothing I do will 
affect my high 
blood pressure 
     
IP16 I have the power to 
influence my high 
blood pressure 
     
IP17 My actions will 
have no affect on 
the outcome of my 
high blood pressure  
     
IP18 My high blood 
pressure will 
improve in time 
     
IP19 There is very little 
that can be done to 
improve my high 
blood pressure  
     
IP20 My treatment will 
be effective in 
curing my high 
blood pressure  
     
IP21 The negative effects 
of my high blood 
pressure can be 
prevented (avoided) 
by my treatment 
     
IP22 My treatment can 
control my high 
blood pressure 




















IP23 There is nothing 
which can help my 
condition 
     
IP24 The symptoms of 
my condition are 
puzzling to me  
     
IP25 My high blood 
pressure is a 
mystery to me 
     
IP26 I don’t understand 
my high blood 
pressure 
     
IP27 My high blood 
pressure doesn’t 
make any sense to 
me 
     
IP28 I have a clear 
picture or 
understanding of 
my condition  
     
IP29 The symptoms of 
my high blood 
pressure change a 
great deal from 
day to day  
     
IP30 My symptoms 
come and go in 
cycles 
     
IP31 My high blood 
pressure is very 
unpredictable 
     
IP32 I go through cycles 
in which my high 
blood pressure gets 
better or worse 
     
IP33 I get depressed 
when I think about 
my high blood 
pressure 





















IP34 When I think about 
my high blood 
pressure I get upset 
     
IP35 My high blood 
pressure makes me 
feel angry 
     
IP36 My high blood 
pressure does not 
worry me 
     
IP37 Having this high 
blood pressure 
makes me feel 
anxious 
     
IP38 My high blood 
pressure makes me 
feel afraid 
 







CAUSES OF MY HIGH BLOOD PRESSURE  
We are interested in what you consider may have been the cause of your illness. 
As people are very different, there is no correct answer for this question. We are most 
interested in your own views about the factors that caused your illness rather than what 
others including doctors or family may have suggested to you. Below is a list of possible 
causes for your illness. Please indicate how much you agree or disagree that they were 









C1 Stress or worry      
C2 Hereditary - it runs in my family      
C3 A Germ or virus      
C4 Diet or eating habits      
C5 Chance or bad luck      
C6 Poor medical care in my past      
C7 Pollution in the environment      
C8 My own behavior      
C9 
My mental attitude e.g. thinking about life 
negatively       
C10 
Family problems or worries caused my 
high blood pressure       
C11 Overwork      
C12 
My emotional state e.g. feeling down, 
lonely, anxious, empty       
C13 Ageing      
C14 Alcohol      
C15 Smoking      
C16 Accident or injury      
C17 My personality      








Hill-Bone Blood Pressure Therapy Scale 
 















      
1. How often do you forget to take your HBP medicine? 1 2 3 4 9 
2. How often do you decide not to take your HBP medicine? 1 2 3 4 9 
3. How often do you leave the pharmacy without obtaining 
your prescribed pills?(due to long line, closure of clinic, 
forgot 1 2 3 4 9 
4. How often do you miss taking your HBP pills when you 
feel sick?       1      2        3             4       9 
5. How often do you run out of HBP pills? 1 2 3 4 9 
6. How often do you skip your HBP medicine 1–3 days 
before you go to the clinic? 1 2 3 4 9 
7. How often do you miss taking your HBP pills when you 
feel better? 1 2 3 4 9 
8. How often do you take someone else’s HBP pills? 1 2 3 4 9 
9. How often do you miss taking your HBP pills when you 








Demographic and Confounding Variable Data 
1. Please write your age in years: _____________ 
2. Which option best fits your educational level? 
a. Less than high school 
b. High school  
c. Some college or trade school 
d. Four-year college or greater 
3. What is your gender?  
a. Male 
b. Female 
4. How long has it been since you were told by a doctor that you have high blood 
pressure? ____________ 
5. Where would you say your systolic (top blood pressure) reading usually is? 
a. 140-159 
b. Greater or equal to 160 
6. Where would you say your diastolic (bottom blood pressure) reading usually is? 
a. 90-99 
b. Greater or equal to 100  








8. Have you ever been diagnosed with depression by a doctor or do you take 
medication prescribed by a doctor or other healthcare providers for depression? 
a. Yes 
b. No 
9. Do you have health insurance plan that pays for your blood pressure medication 
and doctor visit? 
a. Yes 
b. No 



































































        
 
 
        
 
 
        
 
 
        
 
 
        
 
 
        
 
 
        
 
 
        
 
 
        
 
 
        
 Eligibility Criteria: 
1. Black adult male and females—35 to 65 years 
2. Diagnosis of primary hypertension for at least 12 months  
3.  Have been prescribed or is taking at least one hypertensive medication 
4.  Able to read and write in English. 
 Ineligibility Reasons:  
1. Secondary hypertension as supported by history of sleep apnea, renal artery 
disease, stenosis, certain cardiovascular diseases, hyperthyroidism, pregnancy, or 
adrenal gland tumor (pheochromocytoma) 








Appendix G  






















Patient Study number___________________ 
 
1.  Participant’s age in years___________ 
2. Diagnosis of Primary/Essential Hypertension (ICD-10 code: I10) ?:  Yes  or No 
3. Duration of hypertension diagnosis? __________                           
4. Documented diagnosis of depression or taking antidepressant?         Yes   No 
5.   Two most recent systolic blood pressure readings_____________ 
6.  Two most recent diastolic blood pressure reading_____________ 
7. Duration of hypertension diagnosis_____________ 
8. Number of blood pressure medications_________ 
 Decision:  Met inclusion Criteria?   Yes          No 
 If excluded, why (Write in)_________________________ 
 Or choose from exclusion criteria: 
(a) Potential secondary hypertension as supported by history of sleep apnea, renal artery 
disease, stenosis, certain cardiovascular diseases, hyperthyroidism, pregnancy, or adrenal 
gland tumor (pheochromocytoma); 
(b) Severe mental disorder that can hinder comprehension of instructions; 



















































The purpose of this manual is to provide a guideline for data collectors or 
researchers.   This document provides step-by-step instructions for the data collection 
process and is intended for use, to reduce error during the data collection process. 
Purpose of Study 
 To investigate perceptions about causes of hypertension among Black 
hypertensive adults aged 35 to 65 years of age. 
 To examine the relationship between medication adherence and hypertension 
perceptions as related to views about hypertension timeline, controllability, 
consequences, emotional representation, illness coherence, and cause among 
Black hypertensive adults 35 to 65 years old while controlling for depression, 
educational level, duration of diagnosis, hypertension-related symptom, and 
severity of hypertension. 
 To explore to what extent hypertension perceptions and medication adherence 
differ by gender after controlling for confounder. 
 
Study Setting and Population: 
The population of interest for this study is Black hypertensive adults, aged 35 to 
65 years old in primary care settings.  Recruitment/data collection will occur in four 
primary care clinics in Houston Metropolitan area. One of the clinics is a university-
affiliated employee health clinic. 
Approvals and Permissions: 
Study approval was obtained from University of Texas-Houston Health Science 
Center Committee for the Protection of Human Subjects (CPHS). Written permission was 
obtained from management at each of the four sites. 
Role of Principal Investigator 
The Principal Investigator (PI) assumes the responsibility for all aspects of the 
study including proposal development and defense, screening and recruitment, data 
collection, data management, data analysis, data interpretation, writing up the final results 
and report, and presentation of findings.  Furthermore, the PI serves as the coordinator of 






Inclusion Criteria: (a) self-identified Black adults; (b) males and females, aged 35 to 65 
years;  (c) diagnosis of primary/essential hypertension (diagnosis of  essential 
hypertension was confirmed by PI during chart review based on written diagnosis of 
“essential or primary” HTN  or ICD 10 code (I10) in patients’ charts); (d) duration of 
hypertension diagnosis for at least 12 months; (e) had been prescribed or was taking at 
least one hypertensive medication; (e)  ability to read and write in English. 
Exclusion criteria: (a) Secondary hypertension as supported by history of sleep apnea, 
renal artery disease, stenosis, certain cardiovascular diseases, hyperthyroidism, 
pregnancy, or adrenal gland tumor (pheochromocytoma) upon chart review, (b) severe 
mental disorder hindering comprehension of instructions; (c) refusal to provide informed 
consent. 
Study Variables 
Illness Perceptions. This will be measured with revised-illness perception questionnaire. 
IPQ-R has two sections: Illness representation (IR) with 38 items; and the Cause section 
with 18 items. 
Medication Adherence:  This variable will be measured with the nine-item medication 
adherence subscale of the Hill-Bone Blood Pressure Therapy adherence scale. 
Covariates and demographic data:  Demographic data include age, employment status, 
gender, health insurance status.  Covariates include history depression, number of 
hypertension medications, experience of worrisome hypertension symptoms, duration of 
hypertension and hypertension severity. These data will be collected using a designed 
demographic data form designed for this study.  Chart review will also be used to collect 
data on certain covariates. 
Supplies Needed for Recruitment and Data Collection: 
 Copies of the recruitment flyers 
 Copies of  IPQ-R, Hill-Bone and demographic data  questionnaires 
 Copies of informed Consent forms 
 Enrollment Log 
 Copies of PI chart review form 
 Pencils or pens 
 Clip boards 





 Study codes or Numbers 
 Large envelope to store completed questionnaires and PI chart review forms 
 Large envelope to store completed informed consent. 
 
Recruitment Procedure: 
 Before initiation of data collection, the PI will first visit each of the four clinics 
and go over the recruitment process and familiarize himself/herself with the 
clinics. 
 PI will be present at the clinic three to four days a week, rotating between the 
clinics. 
 Recruitment flyer needs to be placed in the lobbies and exam rooms at each of the 
clinics. 
 All data collection will take place in the clinics’ lobbies as the patients wait to see 
their doctors. 
 To maximize the likelihood of recruiting many participants each recruitment day, 
the PI may need to ask the clinic scheduler or front desk staff the days many 
patients that may likely qualify for the study are scheduled. 
 
Data Collection Procedure 
 PI approaches potential participants in the clinics’ lobby with the recruitment 
flyer and gives a brief introduction of the study. 
 Allow potential participants time to read the flyer and ask questions about the 
study. 
 If participant is interested in participating, the PI gives them the informed consent 
form with signature.  Remind participant to thoroughly read the informed consent 
and ask questions before signing, including introduction, benefit, compensation, 
risk and confidentiality. 
 After consent is signed, have participants complete the study questionnaires. 
 Always protect participants’ privacy while collecting data in the lobby. 
 Upon completion of the questionnaires, PI needs to go through the questionnaires 





  Allow each participant to select a $15-dollar Wal-Mart or Starbucks gift card. 
 Every potential participant approached, whether eligible or not, should be logged 
in the “Enrollment log” form and reason for ineligibility documented. 
Post Questionnaire Completion: 
  Assign each participant’s completed questionnaire a study identification code; 
and write the code on each page of the questionnaire. 
 Place each completed questionnaire in the large envelope. 
 Using each participant’s name and date of birth, ask the clinic medical assistant or 
front desk secretary to pull the chart. 
 Conduct the chart review using the form labeled “PI’s chart review form” . 
 At the end of chart review, write each participant’s study identification code on 
the chart review form,  attach it to the completed Illness Perception and Hill-Bone 
medication adherence questionnaires and demographic form, and place them in 
the large envelope. 
 Be careful not to write any participant’s name or date of birth on any of the 
completed questionnaires or chart review form. 
 Place the signed informed consent forms in a large envelope separate from the 
one containing the completed questionnaires. 
 At the end of each recruitment day, count and document the number of remaining 
gift cards. 
Data Management: 
 The PI is responsible for management and storage of all collected data. 
 PI is responsible for entering the date in SPSS. 
 PI and advisor will verify accuracy of data entry. 
 Completed questionnaires and consent forms will be stored in a locked cabinet 









 Data analysis will be conducted by PI with assistance of a statistician. 
 Conduct principal component factor analysis of the 18 causal items of the IPQ-R 
to examine sample’s perceptions about causal attribution of hypertension. 
 Conduct multiple regression to investigate the association between illness 
(hypertension) perceptions and medication adherence. 
 Conduct ANCOVA to explore gender differences in medication and adherence 







Demographics and Covariates Codebook 
Variable SPSS Name Coding instructions 
Identification Code ID As in assigned study ID 
Age Age Age in years 
Educational level Education 1 = less than high school 
2 = high school 
3 = some college or trade school 
4 = four yr college or greater 
Gender Gender 1 = Males 
2 = Females 
How long diagnosed with 
HTN 
HTN duration Enter year (continuous) 
Average systolic BP SBP 1 = 140-159 (mild or stage 1) 
2 = ≥160 (severe or stage 2) 
3 = <140 (normal) 
Average diastolic BP DBP 1 = 90-99 (mild or stage 1) 
2 = ≥100 (severe or stage 2) 
3 = <90 (normal) 
Experience worrisome HTN 
symptoms 
HTN symptoms 1 = Yes 
2 = No 
Ever been diagnosed with 
Depression or take medication 
Depression history 1 = Yes 
2 = No 
Health insurance for doctor 
visit and medication 
Health insurance 1 = Yes 
2 = No 
Employment status Employment 1 = Employed 
2 = Unemployed 
3 = Retired 
HTN medication complexity Number of HTN 
medications 
≤ 2 = Not complex 
≥ 3 = Complex 
 
 
Recruitment site Site 1 = Mercy SW 
2 = AOW 
3 = FMCC 







IPQ-R: IR (P1 to P38) coding 
Variable SPSS label Coding Instruction 
BP lasts a short time IP1 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
BP likely to be permanent than temporary IP2 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
BP last for a long time IP3 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
This HBP will pass quickly IP4 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
I expect to have BP rest of my life IP5 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
BP is a serious condition IP6 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
BP has major consequences IP7 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 






Variable SPSS label Coding Instruction 
BP doesn’t have much effect on my life IP8 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
BP strongly affects the way people see 
me 
IP9 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My BP has serious financial 
consequences 
IP10 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My BP causes difficulties for those close 
to me 
IP11 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
There is a lot I can do to control my 
symptoms 
IP12 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
What I do can determine whether my BP 
gets better or worse 
IP13 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
The course of my BP depends on me IP14 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 








Variable SPSS label Coding Instruction 
Nothing I do will affect my HBP IP15 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
I have the power to influence my HBP IP16 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My actions will have no effect on the 
outcome of my HBP 
IP17 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My HBP will improve in time IP18 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
There is very little that can be done to 
improve my HBP 
IP19 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My treatment will be effective in curing 
my HBP 
IP20 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
The negative effects of my HBP can be 
prevented by my treatment 
IP21 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 









Variable SPSS label Coding Instruction 
My treatment can control my HBP IP22 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
There is nothing which can help my 
condition 
IP23 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
The symptoms of my condition are 
puzzling to me 
IP24 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My HBP is a mystery to me IP25 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
I don’t understand my HBP IP26 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My HBP doesn’t make any sense to me IP27 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
I have a clear picture or understanding of 
my condition 
IP28 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 







Variable SPSS label Coding Instruction 
The symptoms of my HBP change a great 
deal from day to day 
IP29 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My symptoms come and go in cycles IP30 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
MY HBP is very unpredictable IP31 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
I go through cycles in which my HBP 
gets better or worse 
IP32 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
I get depressed when I think about my 
HBP 
IP33 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
When I think about my HBP I get upset IP34 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My HBP makes me feel angry IP35 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 








Variable SPSS label Coding Instruction 
My HBP does not worry me IP36 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Having this HBP makes me feel anxious IP37 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My HBP makes me feel afraid IP38 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 







Causal Attribution Coding 
Variable SPSS label Coding Instruction 
Stress or worry C1 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Hereditary C2 1= Strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Germ or virus C3 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Diet or eating habits C4 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Chance or bad luck C5 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Poor medical care in my past C6 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Pollution in the environment C7 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 






Variable SPSS label Coding Instruction 
My own behavior C8 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My mental attitude C9 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Family problems or worries C10 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Overwork C11 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My emotional state(anxious, 
feeling down, lonely, 
empty) 
C12 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Ageing C13 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Alcohol C14 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 








Variable SPSS label Coding Instruction 
Smoking C15 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Accident or injury C16 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
My personality C17 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 
5= strongly agree 
Altered immunity C18 1= strongly disagree 
2= disagree 
3= neither agree nor disagree 
4= agree 







Hill-Bone HBP scale Codebook 
Variable SPSS label Coding Instruction 
Forget to take BP 
medicine 
HBHBPmed 1 1= none of the time 
2= some of the time 
3= most of the time 
4= all the time 
Decide not to take your 
HBP medicine 
HBHBPmed 2 1= none of the time 
2= some of the time 
3= most of the time 




HBHBPmed 3 1= none of the time 
2= some of the time 
3= most of the time 
4= all the time 
Miss taking HBP 
medicine when feel sick 
HBHBPmed 4 1= none of the time 
2= some of the time 
3= most of the time 
4= all the time 
Run out of HBP pills HBHBPmed 5 1= none of the time 
2= some of the time 
3= most of the time 
4= all the time 
Skip HBP medicine for 
1-3 days before going to 
clinic 
HBHBPmed 6 1= none of the time 
2= some of the time 
3= most of the time 
4= all the time 
Miss taking BP pills 
when feel better 
HBHBPmed 7 1= none of the time 
2= some of the time 
3= most of the time 
4= all the time 
Take someone else’s 
HBP pills 
HBHBPmed 8 1= none of the time 
2= some of the time 
3= most of the time 
4= all the time 
Miss taking your HBP 
pills when you care less 
HBHBPmed 9 1= none of the time 
2= some of the time 
3= most of the time 







Stella Eke, PhD, DNP, RN, FNP-C 
EDUCATION 




Texas Woman’s University 
Denton/Dallas,TX      2011 DNP   
      Nursing  
 
Texas Woman’s University- 
Houston, TX       2008   MS   
Nursing-FNP 
 
Texas Woman’s University- 
Houston, TX       2006      BS   
Nursing  
 
Houston Community College  
Houston, TX       2002  ADN   
Nursing   
 
PROFESSIONAL POSITIONS: 
Mercy Family and Pediatric Clinic             2012-present 
Houston, TX   
  Family Nurse Practitioner 
South University Online program 
Adjunct faculty              2016-present 
 
Houston Community College         
 Adjunct Clinical Faculty            2011-2013 
 
Shoetan Family Clinics- 
Houston, TX  
  Family Nurse Practitioner                 2011-2012                                                         
 
 
Christus Medical Group-Houston 






 The Methodist Hospital 
     Houston, TX 
          Registered Nurse              2003-2008         
 
PROFESSIONAL MEMBERSHIP: 
Sigma Theta Tau International Honor Society of Nursing-   2008-present 
Houston Chapter   
                
Member of Houston Area Nurse Practitioner Organization   2007-present 
 
PUBLICATIONS: 
Eke S.O., Kus, E., Thompson, A. & Mancuso, P. (2011). Primary Hyperparathyroidism: 
A Symptomatically Mild Disease with Serious Complications. Journal for Nurse 
Practitioners (Published June 2011; JNP, Volume 7(6): 479-485) 
 
 
